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Abstract 
Background: Alongside experiencing physical symptoms with no identifiable 
organic cause, patients with MUS commonly experience comorbid anxiety and 
depression. They also have high health utilisation costs, which has implications for 
the health service. Interventions which target these symptoms in a cost effective way 
need to be developed and evaluated.  
Objective: To develop and evaluate a self-help mindfulness-based stress reduction 
(MBSR) intervention for patients with medically unexplained symptoms (MUS).  
Methods: A systematic review of the literature was carried out to evaluate the 
effectiveness of MBSR for reducing psychological distress in people with MUS. 
Study 1 developed and evaluated a self-help MBSR intervention in a clinical setting. 
Fifteen participants were recruited from eight practice, however only five completed 
post-intervention measures. A combination of t-tests and descriptive statistics were 
used to compare changes in levels of psychological distress, quality of life, 
symptoms and mindfulness at post-intervention. Pearson‘s correlations were used to 
identify relationships between improvements in mindfulness and improvements in 
outcomes. Study 2, exploring the reasons for the difficulties recruiting participants to 
Study 1, was then carried out through questionnaires to GPs. 
Results: Though more evidence is needed, the systematic review found MBSR to 
have moderate effects on psychological distress, which are largely maintained or 
improved at follow-up. Study 1 found symptom frequency and levels of acceptance 
to have improved at post-intervention. Study 2 found that the main reasons for GPs 
not recruiting participants was that they were busy and found it difficult to prioritise 
given other demands. 
Conclusions: Evidence to date suggests that MBSR is an effective intervention for 
patients with MUS. Future studies may benefit from recruiting participants from 
relevant organisations or using alternative methods such as database searches. No 
firm conclusions can be made about the self-help MBSR intervention‘s efficacy due 
to the study‘s limitations, however changes seen in the completer group suggest that 
further research would be warranted.  
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Abstract 
Background: Physical symptoms which have no known medical cause are common, 
frequently debilitating, often do not respond to medical treatment and are commonly 
accompanied by psychological distress. Several psychological interventions have 
been trialled to reduce this distress, including Mindfulness-Based Stress Reduction 
(MBSR).  These studies have produced differing outcomes and have not yet been 
reviewed systematically. 
Methods: A literature search for studies of mindfulness-based stress reduction 
interventions for patients with medically unexplained symptoms, which included 
outcomes of psychological distress, was carried out. A number of electronic 
databases were searched; key journals were hand searched; first authors were 
contacted and reference lists of included articles were scanned.  
Results: Nine studies met the inclusion criteria. Effect sizes of the more 
methodologically rigorous studies showed moderate reductions in psychological 
distress in MBSR groups which were largely maintained at follow-up. Many of the 
studies lacked methodological rigour, limiting the conclusions that could be drawn. 
Conclusions: While the current findings suggest that MBSR is moderately effective 
in reducing psychological distress in patients with MUS, there is insufficient 
evidence to conclude that it is more effective than a control. Further 
methodologically-rigorous controlled studies are needed, based on clinical 
populations and with longer follow-up periods.  
Key words: mindfulness meditation, mindfulness based stress reduction, irritable 
bowel, fibromyalgia, chronic fatigue, somatic. 
MUS = medically unexplained symptoms; NHS = National Health Service; CBT = 
cognitive behaviour therapy; MBSR = Mindfulness-based stress-reduction; CRD = 
Centre for Reviews and Dissemination; CF = chronic fatigue; IBS = irritable bowel 
syndrome; DARE = Cochrane database of abstracts of reviews of effects; BSI-A= 
Brief Symptom Inventory – anxiety subscale; BSI-D= Brief Symptom Inventory – 
depression subscale; VSI= Visceral Sensitivity Index; HADS-D=The Hospital 
Anxiety And Depression Scale – depression subscale; HADS-A= The Hospital 
Anxiety And Depression Scale – anxiety subscale; SCL-90-R (GSI)=Symptom 
Checklist-90-Revised (Global Severity Index); SCL-90-Ra=Symptom Checklist-90-
Revised – anxiety subscale; SCL-90-Rd=Symptom Checklist-90-Revised – 
depression subscale; BDI= Beck Depression Inventory; BAI= Beck Anxiety 
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Inventory; CES-D = Center for Epidemiologic Studies Depression Scale; STAI= 
State-Trait Anxiety Inventory. 
1.1. Introduction 
Physical symptoms which are appropriately investigated, but where no organic 
pathology can be identified, are often referred to as medically unexplained symptoms 
(MUS). Such symptoms often include pain, weakness or fatigue, and many areas of 
medical specialism have a diagnostic category for MUS including irritable bowel 
syndrome (IBS; gastroenterology), fibromyalgia (rheumatology) and chronic fatigue 
(1). 
Medically unexplained symptoms have a considerable impact both on the individuals 
and on the healthcare system. Patients presenting with MUS can experience pain, 
distress, discomfort and disability (2) comparable to that caused by identifiable 
disease (3). They also visit their GP often, with prevalence estimates suggesting that 
they account for around a third of hospital outpatient referrals (4) and between 15 
and 30% of patients in primary care (2, 5). As a result, resources can be wasted on 
ineffective attempts at treatment (6), with significant costs to the NHS and the 
potential to cause harm and discomfort through non-essential surgery or investigation 
(7).  
Evidence suggests that a high proportion of patients with MUS experience 
psychological distress. Bleichhardt and colleagues found that 74% of their MUS 
participants had comorbid affective disorders and 47% had comorbid anxiety 
disorders (8). Another study found that 63% of patients with MUS had comorbid 
major depressive disorder (9). There are various possible explanations for these 
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associations with distress.  Sharpe proposes that undiagnosed depression is one of the 
greatest causes of MUS, suggesting that physical symptoms such as fatigue, weight-
loss and more complaints of pain are misdiagnosed, or go undiagnosed, due to the 
mistaken belief that depression is solely a mental health problem (10). For similar 
reasons, he suggests that anxiety and panic are another common cause of MUS.  
Continuing stigma in Western societies toward mental health may increase the 
likelihood of distress being manifested somatically. It is also possible that the distress 
caused by these symptoms leads to anxiety or depression, which in turn serves to 
worsen symptoms. Such self-perpetuating circles, where physical symptoms lead to 
poorer psychological wellbeing which in turn worsens symptoms are recognised in 
many chronic health conditions (11, 12). 
Several psychological therapies have been introduced to this population to help 
manage distress. However, one difficulty faced in the assessment and treatment of 
MUS is that people often believe that problems are either purely physical or purely 
psychological (1). So while there is evidence that cognitive behavioural therapy 
(CBT) can be beneficial for some patients with MUS (13-15), many patients interpret 
a referral to a psychologist, or for the thought-challenging exercises typical of CBT, 
as a rejection or denial of their problems as being real, or feel that they are being told 
that it is ‗all in their head‘. Stone and colleagues found that psychological-sounding 
diagnostic labels often appear offensive to patients who preferred terms such as 
‗stress-related‘ (16). 
Mindfulness provides an alternative, less challenging, stress reduction approach to 
such symptoms which works from a more acceptance-based stance. As a result the 
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focus of MBSR is not upon changing unhelpful thinking, but on changing the process 
by which symptoms are experienced. Mindfulness has been described as ―the 
awareness that emerges by way of paying attention on purpose, in the present 
moment, and non-judgementally to the unfolding of experience moment by moment‖ 
(17; p732). In this way, emotions thoughts and bodily sensations, including negative 
those that are distressing or negative, are considered to be objects of attention in the 
practice of mindfulness. 
Mindfulness-based stress-reduction (MBSR) is traditionally a standardised group-
based therapy which evolved from the integration of Buddhist meditation into 
western psychological and clinical practice and was developed by Jon Kabat-Zinn 
(18).  MBSR has been utilised for many physical problems, such as cancer (19) and 
chronic pain (20), as well as for mental health problems such as anxiety and 
depression (21, 22). As mindfulness does not make judgements about the cause of 
the symptoms, the potential for it to be beneficial for, and acceptable to, patients with 
MUS is promising.   
There is evidence that MBSR has been useful in reducing anxiety and depression in 
people with fibromyalgia (23) and IBS (24), however other studies, such as that by 
Schmidt and colleagues (25), have had more mixed results. There have been no 
systematic reviews in this area to date, though a review of mindfulness for chronic 
pain (involving both explained and unexplained symptoms) identified that there was 
insufficient evidence for mindfulness-based intervention for this population due to 
the limitations of the studies reviewed (26).   
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While most studies in this area focus on one type of MUS such as CF, fibromyalgia 
or IBS, this study looks to review the evidence for MBSR for MUS as a whole. 
Irrespective of the type of symptom, CBT models of MUS propose an autopoietic 
system in which symptoms are self-producing or self-perpetuating. The models 
assume that symptoms are not the result of a physical pathology, but are generated or 
maintained by the interaction of physiological, cognitive and behavioural factors. 
In this way, rather than attach their explanation to a particular bodily system the 
model proposed by Rief and Barsky (2005) suggests that symptoms arise through a 
two stage process of generation and selection. In the first stage chronic stress and 
over-arousal generate bodily symptoms, and in the second stage these symptoms are 
selected for conscious attention through a number of contributing factors including 
depression, health anxiety and uncertainty regarding symptom origins. The model 
suggests that these factors lead to ‗faulty filtering‘ and an increase in the perception 
of, and attention to, symptoms.  
This fits with theories of conscious awareness, including that by Gallagher (2005), 
which propose that while it plays little part in our daily life, and that automatic 
bodily processes remain largely outside our sphere of awareness, at times processes 
and sensations which would normally go unnoticed can be brought to the surface by 
changes in cognition or physiology. These symptoms can then interfere with the 
normal functioning of what are usually unconscious processes. In CBT models of 
MUS such symptoms may themselves become novel aversive stimuli resulting in 
further arousal and the development of a cognitive bias for symptoms leading to 
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increased rumination, with pain and illness leading to more pain and illness (Ursin, 
2005).  
Sometimes difficulties arise amongst healthcare workers around the meaningfulness 
and relatedness of different MUS diagnoses. This model helps to resolve these, to 
some extent, by providing a unified understanding of the nature of symptoms 
regardless of their type.  Furthermore, this universal understanding of the 
maintenance of such symptoms provides potential treatment options, the lack of 
which can lead to concern about giving diagnoses. 
While there have been some positive findings using CBT for this population the 
wider project is interested in the potential development of a self-help intervention  
and as such had to take this into account when considering the intervention. As 
people with MUS often experience being told that what they are experiencing is ‗all 
in their head‘ some of the aspects of CBT, such as thought challenging, might be 
particularly off-putting, particularly with no therapist to engage and validate the 
patient's experience. 
The use of MBSR as a treatment option for patients with MUS fits well with this 
model as it looks to build up the non-judgemental awareness of present moment 
experience, including symptoms, and stepping away from the attributions and 
thoughts that have become caught up in and maintain these experiences. Mindfulness 
looks to break the cycle of rumination through this process, with evidence that higher 
levels of acceptance, which are developed through mindfulness practice, are 
associated with lower rumination, thought suppression and depression (44). 
Alongside the research supporting the use of MBSR in managing symptoms in 
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patients with medically explained symptom, and the evidence that people with MUS 
prefer the term ‗stress-related‘ to more psychological terminology, this model fits 
well with the idea that MBSR may be a useful treatment for this population. As a 
result, the aim of this review is to systematically evaluate the clinical effectiveness of 
MBSR for psychological distress in patients with MUS.  
1.2. Method 
This systematic review was informed by the internationally accepted guidance on 
carrying out systematic reviews provided by the Centre for Reviews and 
Dissemination (CRD) (27). 
1.2.1. Inclusion and exclusion criteria 
Studies were eligible for inclusion if they reported quantitative outcomes of 
psychological distress in people with MUS who had undertaken MBSR. Outcomes of 
psychological distress were defined as those which measured anxiety, depression or 
general psychological wellbeing. People were defined as having MUS if there was no 
identifiable organic pathology to their symptoms which is often identified through 
diagnoses such as CF, IBS and fibromyalgia. Studies were limited to those involving 
adult participants, regardless of race, gender or nationality. 
Published conference abstracts were excluded as insufficient information about these 
studies could be found regarding methodology and results, as were studies where the 
intervention was not based predominantly on Kabat-Zinn‘s original MBSR (18). 
Studies using MBSR alongside another intervention were also omitted.  Unpublished 
theses were included where they could be accessed and met criteria. 
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Studies assessing clinical effectiveness through self-report measures of anxiety, 
and/or depression, and/or a general psychological distress measure, were eligible for 
inclusion.  
1.2.1.1. Literature search 
The literature search was originally carried out in November 2011, and re-run in June 
2012. The Cochrane Database of Abstracts of Reviews of Effects (DARE) was 
searched to check that a similar study had not been carried out recently. To ensure 
that this initial search was as thorough as possible, DARE was searched using the 
following terms: ―medically unexplained‖, ―unexplained medical symptoms‖, 
―chronic fatigue‖, ―irritable bowel‖, and ―mindful*‖ or ―MBSR‖ or ―MBCT‖. The 
search revealed that no other similar review had been conducted.  
The following electronic databases were then searched:  Embase (1990 to 2011); 
Ovid MEDLINE (1990-2011); PsycINFO (1990-2011); and PsycARTICLES (1990 
to 2011). Searches of these databases (in the domains of: title, abstract, heading 
word, table of contents, key concepts, original title, and tests & measures) were 
carried out using the following search string: ('medically unexplained symptom$' or 
'unexplained medical symptom$' or ' somatic symptom$' or 'somatic disorder' or 
'somatoform disorder' or 'functional symptoms' or 'functional syndromes' or 
'functional disorders' or 'somati#ation' OR 'chronic fatigue' OR 'CFS' OR 'myalgic 
encephalomyelitis' OR 'chronic fatigue disorder' OR 'postviral fatigue' OR 
'unexplained fatigue' OR 'post-concuss$' OR 'post concuss$' OR 'irritable bowel' OR 
'IBS' OR 'irritable colon' OR 'spastic colon' OR 'functional adj5 bowel' OR 
'fibromyalgia' OR 'fibromyalgia syndrome' OR 'fibromyalg$' OR 'tension headache' 
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OR 'tension-type headache' OR 'stress headache' OR 'muscle contraction headache') 
AND ('mindfulness-based stress reduction' OR 'mindful$' OR 'MBSR' OR 
'meditation').  
First authors of included papers, and of relevant published abstracts identified in the 
search, were contacted to request details of any unpublished studies that would meet 
the inclusion criteria. Eleven authors were approached, of these two could not be 
contacted and three did not respond. Seven articles (published and unpublished) were 
suggested by the authors who responded, but these either did not meet inclusion 
criteria or were already included in the review.  
The reference lists for each of the included studies were manually searched in 
addition to a manual search of relevant journals which had published papers in this 
area (Journal of Psychosomatic Research, Psychosomatics and Psychotherapy, 
Psychosomatics and Psychosomatic Medicine) between 2009 and 2012. The original 
search yielded 398 potentially relevant papers, of which nine were finally determined 
to meet the review‘s criteria (see Figure 1.2.1).  
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Figure 1.2.1  Flow chart of original literature search process 
The search was re-run in June 2012 returning a further 27 papers, none of which met 
the inclusion criteria. 
1.2.2. Assessing included studies 
The included studies were evaluated using the 12 quality criteria outlined in Table 
1.3 (full details of the criteria available in Appendix 1b). These criteria were based 
on recommendations by the CRD that quality criteria should cover the assessment of: 
chance of bias, outcome measures used, statistical issues, quality of reporting, quality 
of the intervention, and external validity (27). S.M. scored each study on the 12 
quality criteria using the Scottish Intercollegiate Guidance Network (SIGN) outcome 
ratings (‗Well covered‘: 2 points; ‗Adequately addressed‘: 1 point; and ‗Poorly 
addressed‘, ‗Not reported‘ and ‗Not applicable‘: 0 points) (28). Six of the nine 
studies, randomly selected through an online programme at www.random.org, were 
Potentially relevant 
papers screened for 
inclusion: 398 
Papers excluded following 
title/abstract screening: 377 
Provisionally included 
papers: 21 
Papers excluded after further 
investigation of full article: 12 






papers:  9 
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independently reviewed by P.G.M. Initial review found exact agreement on 92% of 
quality ratings; differing by one point on 7%, and by two points on 1% of items. 
Where differences in scores were identified for criteria, these were reviewed and, 
where appropriate, amended. Studies were given an overall methodological strength 
related to their total score on the criteria ranging from Low to Very Good. Outcome 
ratings for individual quality criteria and methodological strength ratings can be seen 
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1.3. Results 
1.3.1. Characteristics of included studies 
Of the 398 articles retrieved in the original search, 377 were excluded following the 
initial title and abstract screening as they clearly did not meet the review‘s criteria. 
Full articles were screened for the remaining 21 articles, which resulted in the 
exclusion of a further 12 studies for reasons outlined in Appendix 1a.  
The nine remaining studies comprised three randomised-controlled trials, two 
controlled trials and four uncontrolled trials. Five of these studies evaluated the 
effects of MBSR on both anxiety and depression; one evaluated its effect on anxiety; 
two on depression; and one on general psychological distress. Study characteristics 
and key findings are outlined in Table 1.1. 




Table 1.1  Characteristics and main findings of included studies 




















Effect sizes for MBSR  
(p value where available) 














































Psychological distress:  MBSR group not 
significantly different post-intervention but 
significant improvement in anxiety compared to 
support group at follow-up. MBSR group also 
showed significantly greater improvements in 
GI-specific anxiety at follow-up. Significant 
change in depression in MBSR group at follow-
up. Other: IBS symptom severity reduced in 
MBSR group post-intervention. Improvement 































Psychological distress: MBSR group 
significantly improved compared to the control 
group. Gains largely maintained at 3-year 
follow-up.  Other: Pain, coping and QoL all 
significantly improved in MBSR group 
compared to control at post-intervention and 














R (GSI)  
- - Psychological distress: Improvement in 
psychological distress post-intervention.  Other: 
Mean improvements on all scales post-
intervention. Fifty-one % ‗responders‘ (25% 













Psychological distress: Non-significant change 
in GI-specific anxiety at post-intervention, 
significant change at follow-up. Significant 
correlation between change in anxiety and 
mindfulness over the three time periods. Other: 
Participants experienced significant 
improvements in IBS-related QoL at follow-up. 






















Effect sizes for MBSR  
(p value where available) 























- Psychological distress: Non-significant reduction in 
psychological distress post-intervention. Other: 
Significant reduction in physiological response 



















Psychological distress: Significant improvement in 
depressive symptoms post-intervention. Gains 
reduced at follow-up.  Other: Improvements in QoL, 
pain and coping post-intervention were lost at post-
intervention. Participant who continued practice post 





























Psychological distress: Significantly greater 
improvement for MBSR group in depression and 
anxiety post-intervention and at follow-up. Other: 
Five of nine subscales at post-intervention, and eight 
out of nine at follow-up, showed significant 

































Psychological distress: The active treatment groups 
(MBSR and relaxation group) showed significantly 
greater reduction in anxiety than the waiting list group 
post-intervention. Trend towards greater effect size in 
MBSR for depression but not significant. Other: 
MBSR was no better than wait list or active control in 
terms of HRQoL at post-intervention. At follow-up 








Waiting  list 
(40/27) 








Psychological distress: Significant improvement in 
depressive symptoms in MBSR compared to control 
group post-intervention. Gains maintained at follow-up. 




Table 1.2  Quality ratings of methodology for included studies 
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Table 1.3  Brief description of quality criteria 
 (i) Eligibility criteria are specified 
(ii) Patients are recruited in a clinical setting 
(iii) A control group is used 
(iv) At least one of the therapists was experienced or trained in teaching mindfulness 
(v) Measures of psychological distress are robust 
(vi) Similar levels of psychological distress at baseline 
(vii) The intervention is both sufficiently defined and delivered as planned (i.e.  
demonstrates good fidelity) 
(viii) The assignment of subjects to treatment and control groups is randomised 
(ix) Sample size is adequate for analyses 
(x) Levels of attrition are reported, acceptable, and equivalent for treatment versus 
control 
(xi) The intervention is evaluated for an appropriate duration 
(xii) Appropriate analysis used 
 
A more detailed operationalisation of quality criteria scoring guidelines can be found 
in Appendix 1b. 
1.3.2. Quality of included studies 
The ratings for the quality criteria of each of the included studies are shown in Table 
1.2 alongside a brief description of  the related quality criteria in Table 1.3. While the 
ratings do not provide a comparative measure across studies they give a guide to 
their relative methodological strengths and weaknesses.  
As none of the included studies were explicit about the validity or reliability of their 
measures, the psychometric properties were examined for all of the measures of 
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psychological distress. In addition, effect sizes for measures of psychological distress 
at post-intervention and follow-up were calculated, where possible, if not included in 
the studies. As only half of the studies were controlled, and fewer still included 
group-by-time interaction information, the focus of this review is largely on the 
effect of the MBSR group on psychological distress. 
The study by Schmidt and colleagues (25), and that by Gaylord and colleagues (24) 
received the highest methodological rating score, and were the only studies to be 
rated as well covered or adequately addressed for all criteria, suggesting that they are 
the strongest studies methodologically.   
1.3.2.1. Chance of bias 
Gaylord and colleagues (24), and Kearney and colleagues (30) followed closely by 
Schmidt and colleagues (25) and Grossman and colleagues (23), scored more than 
other studies on quality criteria items that were interested in reducing chance of bias 
(i. Eligibility, ii. Recruitment, viii. Randomisation, x. Attrition, and xi. Evaluation). 
Only three studies suitably randomised their sample to MBSR and control groups 
(24, 25, 34), with only Gaylord‘s study describing the method of randomisation. 
Other studies either did not use random allocation or they had no control group. In 
three of the studies (23, 30, 32) levels of attrition were clearly detailed for treatment 
and control groups, acceptable, and sufficiently alike between conditions. With the 
exception of two studies (31, 33), where levels of attrition were below acceptable 
levels, other studies met the attrition criterion adequately.  
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Recruitment and evaluation criteria are considered separately under the External 
validity section (1.3.2.5). 
1.3.2.2. Outcome measures  
Outcome measures used in all studies were found to be reasonably robust, however 
three studies (31, 32, 34) used measures that are not ideal for this population (such as 
the BDI, BAI and SCL-90-R GSI) as they include somatic items which could 
artificially inflate distress scores in samples with medically unexplained symptoms.  
1.3.2.3. Statistical issues 
Statistical issues (iii. Control; iv. Baseline similarities; ix. Sample size; xii. Analysis) 
were well managed by some of the studies, but poorly by others. Only five of the 
nine studies had controls, however those that did provided clear details of differences 
in psychological distress at baseline between groups and were sufficiently alike or 
differences were controlled for. Most of the studies had sample sizes which were 
sufficient to be considered suitably powered to allow simple main effects (in 
uncontrolled trials) and interaction effects (in studies with control groups) analyses at 
post-intervention. Only two, uncontrolled, studies did not have a sufficient number of 
participants completing pre- and post-intervention measures to enable a power of at 
least 0.7 for simple main effects (31, 32). Analyses were described sufficiently to 
determine that they were conducted appropriately at post-intervention by three 
studies (24, 25, 34). A number of studies did not use intention to treat (ITT) 
principles to incorporate results for participants who did not complete post-
intervention measures in their analyses (23, 29, 31, 33). One study, which stated that 
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ITT was used, did not provide clear details of this (30), while another did not explain 
why non-parametric analyses were being used over parametric alternatives (32). 
Generally, the analyses carried out by uncontrolled studies were not carried out or 
described as well as those carried out in by the controlled studies. Alongside the lack 
of a control, and their inability to compare baseline scores, this lack of clear and 
suitable analyses impacted on the statistical quality, and general methodological 
shortcomings of the uncontrolled studies.  
Overall, the studies by Gaylord (24), Schmidt (25), and Sephton (34) were the 
strongest of the studies in terms of statistical issues, closely followed by those by 
Grossman and Sampalli (23, 33). One study failed to meet any of the criteria for 
statistical issues (31) and another only scored one point (32).  
1.3.2.4. Quality of the intervention 
The quality of the intervention (iv. Therapist experience; iv. Fidelity) was covered 
relatively well by studies. Most provided evidence to show that at least one of the 
trainers was experienced or trained in teaching mindfulness, with only one study not 
providing sufficient information to meet the criterion adequately (29). Most of the 
studies defined the intervention well, and appeared to deliver it as planned. Two 
studies (29, 31), however, did not provide sufficient information to replicate the 
intervention. 
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1.3.2.5. External validity 
Ratings of external validity (ii. Recruitment; xi. Evaluation) varied between studies. 
Recruitment of participants, for example, was carried out in very different ways 
ranging from a pure clinical setting, where no potential bias could be identified (30, 
33), to recruitment through advertising (31, 32, 34) and registries of patients who 
identified themselves as being interested in taking part in research (24). 
Other than two studies (29, 31), most studies included a follow-up period in their 
evaluation. However, only four studies included a follow-up that was at least three 
months post-intervention (23, 24, 30, 33), and Grossman and colleagues‘ study, with 
a three year follow-up, was the only one to include an evaluation over four months 
post-intervention. 
1.3.3. Effectiveness of MBSR 
1.3.3.1. Anxiety 
Post-intervention effect sizes for reductions in anxiety, in MBSR groups, ranged 
from d = 0.16 to 0.68 (see Table 1.1). Studies rated as methodologically Good or 
Very Good showed a trend towards a medium effect size for anxiety post 
intervention, with all studies except one ranging from d = 0.37 to d = 0.68 (23-25, 
30, 33). The exception to this was Kearney and colleagues‘ study which found a non-
significant effect for gastro-intestinal specific anxiety with an effect size of d = 0.16, 
though this did increase to a significant effect of d = 0.40 at follow-up (30). Only one 
of the studies rated as Medium or Low, methodologically, evaluated and included 
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effect sizes for anxiety (31). This study showed an effect size of d = 0.33 which was 
slightly lower than the more methodologically rigorous studies.  
1.3.3.2. Depression 
A clearer difference between stronger and weaker studies is apparent in relation to 
post-intervention depression effect sizes. Studies rated as having Medium or Low 
methodological strength identified a medium to large range of effect sizes from d = 
0.42 to d = 0.64. Stronger studies showed post-intervention effect sizes for 
depression in the small to medium range (d = 0.15 to 0.55) with the two studies rated 
as Very Good reporting effect sizes of d = 0.15 and d = 0.21 (24, 25). The effect 
sizes in these Very Good studies increased to d = 0.29 and  d = 0.36, however, at 
follow-up. 
1.3.3.3. Group comparisons 
The study by Schmidt and colleagues, which had the largest total sample size of 148, 
carried out a post-hoc analysis of the group by time interaction (25). While there was 
no significant difference at post-intervention, MBSR performed significantly better 
than group relaxation and waiting list arms at follow-up. This finding was supported 
by the moderately sized study by Gaylord and colleagues (66 participants) (24): no 
significant interaction was identified for anxiety or depression at post-intervention, 
but at follow-up the MBSR arm performed significantly better than the control in 
both anxiety and GI-specific anxiety, but not depression. Grossman and colleagues‘ 
study (23), with a smaller total sample size of 48 participants, only reported group by 
time interactions for post-intervention data. When comparing the MBSR group with 
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the social support group they found that the MBSR group performed significantly 
better, reporting a small-medium post-intervention interaction effect size (d=0.39) for 
reduction in depression, and a medium-large effect size (d=0.67) in anxiety 
reduction, at post-intervention.  
1.4. Discussion 
The aim of the current article was to review studies which evaluated the impact of 
MBSR in reducing psychological distress in people with MUS. Methodologically, 
the quality of the studies reviewed varied greatly. Few studies incorporated a 
randomised controlled design, and baseline differences were not always measured or 
controlled for where necessary. Even the most methodologically rigorous studies 
showed limitations, with recruitment taking place through media advertisements 
rather than in a clinical setting in both studies (24, 25), and Schmidt and colleagues 
including a relatively short evaluation period of two months.  
Overall these studies suggest that MBSR has a moderate beneficial effect on anxiety. 
In terms of depression, the stronger studies suggest a small to medium beneficial 
effect at post-intervention, compared to larger effects seen in the weaker studies. It is 
notable that effect sizes tended to improve or remain similar to post-intervention 
sizes at follow-up. One of the methodologically strongest, and largest of the studies 
(25), identified a significant group by time interaction suggesting that at follow-up 
MBSR had a greater impact on psychological distress than a relaxation group or 
waiting list control. Unlike other interventions, mindfulness-based interventions 
might show greater effects at follow-up compared to post-intervention because 
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efficacy grows as skills improve with practice, which may explain the findings 
identified here.  
Follow-up periods in the studies reviewed were generally quite short, with most 
studies limited to 2-3 months. The one study with a considerably longer follow-up 
period (23), of three years, identified that gains from post-intervention were largely 
maintained at three-year follow-up. 
Few studies included an active control, designed to be equivalent in structure, 
expectancy and support provided by a group, but excluding the ‗active ingredient‘ of 
mindfulness meditation. As such, while the current evidence suggests beneficial 
effects of MBSR at follow-up -- which exceed those of waiting list or support groups 
-- the small number of randomised controlled studies available at present does not 
allow firm conclusions to be drawn as to whether these are specific effects of MBSR 
or non-specific effects of a psychological intervention. 
1.4.1. Strengths of the review 
The first authors of included papers, and those who had published abstracts which 
appeared relevant, were contacted to identify any unpublished studies with a view to 
limiting the potential for publication bias. A transparent process of methodological 
review was developed, with quality criteria outlined which are tailored to the nature 
of the reviewed studies. A high level of inter-rater reliability was established when 
the methodological quality of the studies was reviewed independently by two raters, 
in order to reduce potential for subjective bias.  
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1.4.2. Limitations of the review 
Though there has been a growth in the number of studies evaluating MBSR for MUS 
in recent years the number of published, and unpublished, studies in the area remains 
limited at present. This means that there is not a large enough sample to compare 
effects across, and within, separate diagnostic groups such as irritable bowel 
syndrome, chronic fatigue, and fibromyalgia, which would prove informative in the 
future if research in this area continues to grow.  
Much of the recent growth in this area of the literature has used MBSR. This, in 
addition to the evidence that suggests that patients with MUS prefer the term ‗stress-
related‘ to more psychological-sounding terms to describe their difficulties (16), led 
to the review‘s focus specifically on the effectiveness of MBSR for this population. 
There are clearly similarities between MBSR and other interventions such as MBCT 
and ACT, including the use of mindfulness and the concept of acceptance. They are, 
however, independent interventions which incorporate different elements such as 
traditional cognitive behavioural therapy. Limiting the review to studies evaluating 
MBSR meant that the review could not make comparisons between the effectiveness 
of MBSR and other interventions. Future studies and reviews would benefit from 
considering such evaluation, particularly when the literature in this area has grown to 
allow more meaningful comparisons between, as well as within, different 
interventions. 
The current review looked to evaluate the effectiveness of MBSR in patients with 
MUS, however it was limited to studies which included distress measures. The 
majority of outcome studies evaluating MBSR in this population included a 
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psychological distress outcome measure. The inclusion of other types of outcome 
measure varies greatly across the available literature from physiological measures to 
problem-specific symptom measures. With such a diversity and inconsistency of 
outcome areas in a relatively small area of literature it was not deemed possible or 
appropriate to compare or synthesise them here. Consequently this review focused 
upon the impact of MBSR upon psychological distress, and as such could not explore 
the potential benefits of MBSR in other areas such as symptoms or quality of life, in 
the MUS population. As a result, the review can only comment on effectiveness in 
terms of the impact of MBSR on distress levels in patients with MUS. Again, as the 
literature grows the evaluation of MBSR on other non-distress parameters would be a 
valuable addition to our knowledge of this area.  
1.4.3. Implications for clinical practice and research 
As patients with MUS have high healthcare costs (6), in addition to the wider 
economic impact associated with sick leave and not working, finding an effective 
and acceptable intervention for patients is vital. The current findings suggest that 
MBSR could, potentially, be a useful intervention for this population that GPs often 
find difficult to manage. The focus on stress reduction, and on managing symptoms 
regardless of cause, means that MBSR may appear a less threatening, and potentially 
more acceptable, intervention to patients who might reject a more ―thought-
challenging‖ psychological intervention such as CBT. In addition, MBSR is 
delivered in groups which would be a more cost-effective intervention than 
individual CBT. In this way, MBSR has the potential not only to reduce the health-
care costs of this population, but to do so in a cost-effective way. However, as the 
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numbers of patients who present at GPs with MUS is high (2, 5), and not everyone is 
open to attending group interventions, a substantial proportion of this population 
would not receive this intervention.  
While the current review suggests that MBSR may be moderately effective in the 
reduction of psychological distress in patients with MUS, more methodologically 
rigorous, well-powered, randomised controlled studies, carried out on clinical 
populations, with longer follow-up periods, need to be carried out in order to 
generate more conclusive findings.  
In addition, identifying what makes patients more likely to benefit from MBSR 
would be beneficial as it could help inform GP referrals for such an intervention, 
particularly considering the large potential population. Analysis of economic 
costs/benefits of MBSR for this population (using healthcare costs calculated on GP 
attendance pre- and post-intervention, for example), and an exploration of self-help 
based MBSR, which could potentially reach a larger proportion of the MUS 
population, would also be useful additions to this area of research.   
1.5. Conclusions 
This systematic review of the effectiveness of MBSR on psychological distress in 
patients with MUS found that it has a moderate effect on psychological distress. 
These effects were largely maintained or improved at follow-up, suggesting that, 
unlike some other therapies, gains made during the intervention may continue 
afterwards rather than diminish. While levels of depression and anxiety were lowered 
by MBSR, the limitations of the studies included meant that firm conclusions about 
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specific effects of MBSR compared to controls or alternative interventions could not 
be drawn. MBSR has the potential to offer patients with MUS a cost-effective 
intervention which is acceptable to them and successful in reducing psychological 
distress. However, more methodologically rigorous controlled trials based on clinical 
populations, with longer follow-up periods, are needed for these potential benefits to 
be substantiated, and for MBSR to be fully recognised as an evidence-based therapy 






   
45 
1.6. References 
1. Hatcher S, Arroll B. Assessment and management of medically unexplained 
symptoms. BMJ 2008;336 :1124-1128  
2. de Waal, M. W. M., Arnold IA, Eekhof JAH, van Hemert AM. Somatoform 
disorders in general practice. Prevalence, functional impairment and 
comorbidity with anxiety and depressive disorders. Br J Psychiatry 2004;184 
:470-476  
3. Carson AJ, Ringbauer B, Stone J, McKenzie L, Warlow C, Sharpe M. Do 
medically unexplained symptoms matter? A prospective cohort study of 300 
new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiatry 
2000;68 :207-210  
4. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms. An 
epidemiological study in seven specialities. J Psychosom Res 2001;51 :361-367  
5. Fink P, Sørensen L, Engberg M, Holm M, Munk-Jørgensen P. Somatization in 
primary care. Prevalence, health care utilization, and general practitioner 
recognition. Psychosomatics 1999;40 :330-338  
6. Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and 
costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 
2005;62 :903-910  
7. Fink P. Surgery and medical treatment in persistent somatizing patients. J 
Psychosom Res 1992;36 :439-447  
8. Bleichhardt G, Timmer B, Rief W. Cognitive-behavioural therapy for patients with 
multiple somatoform symptoms—a randomised controlled trial in tertiary care. J 
Psychosom Res 2004;56 :449-454  
   
46 
9. Escobar JI, Gara M, Silver RC, Waitzkin H, Holman A, Compton W. Somatisation 
disorder in primary care. Br J Psychiatry 1998;173 :262-266  
10. Sharpe M. Medically unexplained symptoms and syndromes. Clin Med 2002;2 
:501-504  
11. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with 
increased health care use and expenditures in individuals with diabetes. Diabetes 
Care 2002;25 :464-470  
12. Xu W, Collet J, Shapiro S, Lin Y, Yang T, Platt RW, Wang C, Bourbeau J. 
Independent effect of depression and anxiety on chronic obstructive pulmonary 
disease exacerbations and hospitalizations. Am J Respir Crit Care Med 
2008;178 :913-920  
13. Nezu AM, Nezu CM, Lombardo ER. Cognitive-behavior therapy for medically 
unexplained symptoms: A critical review of the treatment literature. BEHAV 
THER 2001;32 :537-583  
14. Moss-Morris R, McAlpine L, Didsbury LP, Spence MJ. A randomized controlled 
trial of a cognitive behavioural therapy-based self-management intervention for 
irritable bowel syndrome in primary care. Psychol Med 2010;40 :85-94  
15. Bernardy K, Fuber N, Kollner V, Hauser W. Efficacy of Cognitive-Behavioral 
Therapies in Fibromyalgia Syndrome - A Systematic Review and Metaanalysis 
of Randomized Controlled Trials. J Rheumatol 2010;37 :1991-2005  
16. Stone J, Wojcik W, Durrance D, Carson A, Lewis S, MacKenzie L, Warlow CP, 
Sharpe M. What should we say to patients with symptoms unexplained by 
disease? The "number needed to offend". BMJ 2002;325 :1449-1450  
17. Kabat-Zinn J. Commentary on Majumdar et al.: Mindfulness meditation for 
health. J Altern Complement Med 2002;8 :731-735  
   
47 
18. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind 
to face stress, pain and illness. New York: Delacorte; 1990  
19. Lengacher CA, Johnson-Mallard V, Post-White J, Moscoso MS, Jacobsen PB, 
Klein TW, Widen RH, Fitzgerald SG, Shelton MM, Barta M, Goodman M, Cox 
CE, Kip KE. Randomized controlled trial of mindfulness-based stress reduction 
(MBSR) for survivors of breast cancer. Psychooncology 2009;18 :1261-1272  
20. Plews-Ogan M, Owens JE, Goodman M, Wolfe P, Schorling J. A pilot study 
evaluating mindfulness-based stress reduction and massage for the management 
of chronic pain. Br J Psychiatry 2005;20 :1136-1138  
21. Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based 
therapy on anxiety and depression: A meta-analytic review. J Consult Clin 
Psychol 2010;78 :169-183  
22. Vollestad J, Sivertsen B, Nielsen GF. Mindfulness-based stress reduction for 
patients with anxiety disorders: Evaluation in a randomized controlled trial. 
Behav Res Ther 2011;49 :281-288  
23. Grossman P, Tiefenthaler-Gilmer U, Raysz A, Kesper U. Mindfulness training as 
an intervention for fibromyalgia: Evidence of postintervention and 3-year 
follow-up benefits in well-being. Psychother Psychosom 2007;76 :226-233  
24. Gaylord SA, Palsson OS, Garland EL, Faurot KR, Coble RS, Mann JD, Frey W, 
Leniek K, Whitehead WE. Mindfulness training reduces the severity of irritable 
bowel syndrome in women: Results of a randomized controlled trial. Am J 
Gastroenterol 2011;106 :1678-1688  
25. Schmidt S, Grossman P, Schwarzer B, Jena S, Naumann J, Walach H. Treating 
fibromyalgia with mindfulness-based stress reduction: Results from a 3-armed 
randomized controlled trial. Pain 2011;152 :361-369  
   
48 
26. Chiesa A, Serretti A. Mindfulness-based interventions for chronic pain: A 
systematic review of the evidence. The Journal of Alternative and 
Complementary Medicine 2011;17 :83-93  
27. Akers J. Systematic reviews: CRD's guidance for undertaking reviews in health 
care York: Centre for Reviews and Dissemination, University of York; 2009  
28. Scottish Intercollogiate Guidelines Network. SIGN 50: A guideline developer's 
handbook. 2008.  
29. Kaplan KH, Goldenberg DL, Galvin-Nadeau M. The impact of a meditation-
based stress reduction program on fibromyalgia. Gen Hosp Psychiatry 1993;15 
:284-289  
30. Kearney DJ, McDermott K, Martinez M, Simpson TL. Association of 
participation in a mindfulness programme with bowel symptoms, 
gastrointestinal symptom-specific anxiety and quality of life. Aliment 
Pharmacol Ther 2011;34 :363-373  
31. Lush E, Salmon P, Floyd A, Studts JL, Weissbecker I, Sephton SE. Mindfulness 
meditation for symptom reduction in Fibromyalgia: Psychophysiological 
correlates. J Clin Psychol Med S 2009;16 :200-207  
32. Quintana M, Rincon Fernandez ME. Efficacy of mindfulness training for 
fibromyalgia patients. Clinica y Salud 2011;22 :51-67  
33. Sampalli T, Berlasso E, Fox R, Petter M. A controlled study of the effect of a 
mindfulness-based stress reduction technique in women with multiple chemical 
sensitivity, chronic fatigue syndrome, and fibromyalgia. J.Multidiscip Healthc. 
2009;2 :53-59  
34. Sephton SE, Salmon P, Weissbecker I, Ulmer C, Floyd A, Hoover K, Studts JL. 
Mindfulness meditation alleviates depressive symptoms in women with 
   
49 
fibromyalgia: Results of a randomized clinical trial. Arthrit Care Res 2007;57 
:77-85  
   
50 
1.7. Appendices 
Appendix 1a. Table of studies excluded at second screening and reason for 
exclusion 
Study Reason for exclusion 
Asare et al. (2011)  Journal letter 
Astin et al. (2003)  MBSR not sole intervention (also Qigong movement 
therapy) 
Ernst et al. (2007)  No English version available 
Fjorback et al. (2011 Published conference abstract 
Gaylord et al.  (2011a)  Published conference abstract 
Kearney et al.  (2010a)  Published conference abstract 
Kearney et al.  (2010b)  Published conference abstract 
Kearney et al.  (2011)  Published conference abstract 
Pauzano-Slam (2005)  Thesis - could not be sourced and author could not be 
reached 
Surawy et al. (2005)  MBSR not sole intervention (combined with MBCT) 
Weissbecker et al. (2002)  Not an outcome study 
Zernicke et al.  (2011) Published conference abstract 
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Appendix 1b. Detailed breakdown of quality criteria scoring guidelines 
i. Eligibility criteria are specified 
Well-covered (2) Inclusion criteria clearly detailed  
Adequately addressed (1) Inclusion criteria are not outlined clearly, though they can be 
ascertained from the details given. 
Poorly  addressed (0) Some information is given about eligibility for the trial, though it 
could not be confidently replicated. 
Not  addressed (0)  
Not applicable (0)  
 
ii. Patients are recruited in a clinical setting 
Well-covered (2) It is clear that patients have been recruited in a clinical setting and 
all (or random sample of) eligible potential participants were 
invited. 
Adequately addressed (1) Patients recruited in a clinical setting but potential bias in those 
approached that wasn‘t part of inclusion/exclusion criteria. 
Poorly addressed (0) Patients recruited in a clinical setting but clear bias in those 
approached that was not part of inclusion/exclusion criteria. 
Not addressed (0) Not recruited in a clinical setting 
Not applicable (0)  
 
iii. A control group is used 
Well-covered (2) A suitable control group is carried out alongside the experimental 
intervention group. This could be a TAU, waiting list or an active 
control group.  
Adequately addressed (1) An alternative intervention group is included but no control group. 
Poorly addressed (0)  
Not addressed (0)  









   
52 
 
iv. At least 1 of the therapists was experienced or trained in teaching mindfulness 
Well-covered (2) Evidence provided to show that at least one of the trainers was 
experienced or trained in teaching mindfulness (yrs experience etc) 
Adequately addressed (1) It is stated that one of the therapists is experienced or trained in 
mindfulness but no evidence is given to support this. 
Poorly addressed (0) Some information about the therapist‘s experience given but does 
not suggest ‗experienced‘.  
Not addressed (0) No description of the therapist‘s experience is given. 
Not applicable (0)  
 
v. Measures of psychological distress are robust 
Well-covered (2) Outcome measures robust for this population (valid, reliable - 
HADS, etc.) 
Adequately addressed (1) Outcome measures acceptable validity/psychometrics, or good 
robustness but not the most valid for this population. (GSI of SCL-
R-90/BDI etc) 
Poorly addressed (0) Outcome measures poorly described and less robust. 
Not addressed (0)  
Not applicable (0)  
 
vi. Similar levels of psychological distress at baseline 
Well-covered (2) Clear details of differences in psychological distress at baseline, 
between groups. Sufficiently alike or controlled.  
Adequately addressed (1) Reasonable detail of psychological distress measure between 
groups, and somewhat alike at baseline. 
Poorly addressed (0) Measured but limited description, poorly alike at baseline. 
Not addressed (0)  















vii. The intervention is both sufficiently defined and delivered as planned (i.e. 
demonstrates good fidelity). 
Well-covered (2) The intervention is clearly outlined and shows good treatment 
fidelity – could be replicated. 
Adequately addressed (1) Some detail about the intervention, evidence of alteration of 
intervention from its original form. 
Poorly addressed (0) Unclear definition of the intervention and its fidelity.  
Not addressed (0)  
Not applicable (0)  
 
viii. The assignment of subjects to treatment and control groups is randomised 
Well-covered (2) Randomisation is clearly described using an appropriate method 
Adequately addressed (1) It is stated that randomisation is carried out, but no explanation of 
method. 
Poorly addressed (0) Randomisation is stated, but not using appropriate method.  
Not addressed (0)  
Not applicable (0)  
 
ix. Sample size adequate for analyses 
Well-covered (2) The number of participants who completed pre- and post-
intervention measures was sufficient to enable Power of at least 0.8 
for simple main effects (uncontrolled trials) and interaction effects 
(where 2+ groups). Effect size was anticipated to be medium and 
alpha was 0.05. 
Adequately addressed (1) The number of participants who completed pre- and post-
intervention measures was sufficient to enable Power of at least 0.7 
for simple main effects (uncontrolled trials) and interaction effects 
(where 2+ groups). Effect size was anticipated to be medium and 
alpha was 0.05. 
Poorly addressed (0) The number of participants who completed pre- and post-
intervention measures did not enable Power of at least 0.7 for simple 
main effects and interaction effects (where there are 2+ groups). 
Effect size was anticipated to be medium and alpha was 0.05.  
 
Not addressed (0)  
Not applicable (0)  
 
 





x. Levels of attrition are reported, acceptable, and equivalent for treatment versus 
control 
Well-covered (2) Levels of attrition (from allocation to group to completion of post 
intervention measures) are clearly detailed for both treatment and 
control groups (where present) and are sufficiently alike between 
conditions (within 10% of each other and less than 20% of total 
participants) 
Adequately addressed (1) Reasonable description of attrition (from allocation to group to 
completion of post intervention measures), somewhat alike between 
conditions (within 20% of each other), less than 30% of total 
participants. 
Poorly addressed (0) Poorly described (lacking specifics), or significantly different 
between conditions. 
Not addressed (0) Not described 
Not applicable (0)  
 
xi. The intervention is evaluated for an appropriate duration 
Well-covered (2) Follow-up carried out for a minimum of 3 months (must include 
psychological distress measure) 
Adequately addressed (1) Follow-up carried out for a minimum of 1 month (must include 
psychological distress measure) 
Poorly addressed (0) Follow-up less than one month 
Not addressed (0) No follow-up 
Not applicable (0)  
 
xii. Appropriate analysis 
Well-covered (2) Analysis described sufficiently to determine that analyses conducted 
appropriately at post-intervention - appropriate statistics used, ITT 
where there is attrition. 
Adequately addressed (1) Reasonably clear that appropriate analysis carried out at post-
intervention - appropriate statistics used, ITT where there is attrition 
– maybe lacking in clarity/detail about. 
Poorly addressed (0) Inappropriate analyses or not addressing attrition, where relevant, at 
post-intervention. 
Not addressed (0)  
Not applicable (0)  
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The original study design was a randomised controlled trial, with participants 
recruited to intervention and treatment as usual (TAU) conditions. Due to difficulties 
recruiting participants the design was altered to a within subjects, repeated measures 
study. Figure 2.3.1 illustrates the study design and subject recruitment and response. 
2.2. Ethical considerations 
Ethical approval was granted by the South of Scotland Research Ethics Committee 3 
in November 2011 (see Appendix 3) and NHS Borders Research Governance 
Committee approved the study for their health board (December 2011; Appendix 4). 
In addition, methodological approval was also granted by the University of 
Edinburgh Clinical Psychology Review Team (October 2011; Appendix 5). 
The main ethical considerations were around consent and confidentiality and 
potential distress caused by completing the questionnaires or carrying out the 
intervention. Potential participants were given an information sheet (see Appendix 
6a) which gave details about the project. It explained that patient names and 
addresses were needed so that intervention packs and questionnaires could be sent 
out to them. The information sheet included contact details for the lead researcher if 
participants had any further questions. Confidentiality was maintained by giving 
participants a project ID number as soon as they responded, keeping personal data 
separate to the anonymised data collected. Participants were advised, through the 
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questionnaires and intervention booklet, that if they became distressed at any time, 
they should seek further help from their general practitioner (GP).  
2.3. Participants 
Initially, GPs in six medical practices in NHS Borders were involved in identifying 
patients eligible for the project during routine appointments. During the recruitment 
period, two additional medical practices became involved in identifying potential 
participants.  
Project information packs were given out by GPs to patients who met the inclusion 
criteria and indicated an interest in the research. Patients who completed and returned 
the enclosed consent form and questionnaire became participants. 
Sixteen patients were recruited. Of these, one was randomised to the TAU arm prior 
to the amendment to the design of the project. The remaining fifteen patients were 
recruited to the intervention (see Figure 2.3.1.) and became participants.  
2.3.1. Inclusion criteria 
To be eligible for inclusion in the project, patients needed to: 
 Be identified by their GP as having at least one of the following conditions: 
irritable bowel syndrome, chronic fatigue syndrome, tension headaches or 
fibromyalgia. 
 Have received appropriate investigation to exclude known medical 
explanations for symptoms (as determined by their GP). 
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 Have no known medical basis or partial basis for the symptoms (as 
determined by their GP). 
 Have sufficient understanding of the English language to complete the 
standardised measures. 















Figure 2.3.1  Participant recruitment and response numbers 
2.4. Measures 
Participants completed outcome and process measures upon entry to the study 
(baseline), at completion of the 8-week intervention period (post-intervention). 
Measures were collated in an A5 booklet. The baseline measures were given out by 





Number of participants who completed 
and sent back baseline project packs: 
16 
 
Number of participants randomised 
to intervention arm: 
15 
 
Number of participants 
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GPs in the project information packs, the post intervention measures were sent out to 
participants with return envelopes.  
The baseline questionnaire booklet asked participants for their age, sex, main 
symptom, and length of time they had experienced their symptoms for. The post-
intervention measures booklet included a short additional section asking participants 
for feedback on the intervention and how far they had completed the intervention on 
a five point scale from ‗completely‘ to ‗not at all‘. The following outcome and 
process measures were included at each time point: 
2.4.1. Hospital Anxiety and Depression Scale (HADS) 
The Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) was used to 
measure psychological distress. The HADS is a self-report measure which was 
initially designed for the identification of anxiety and depression in a non-psychiatric 
hospital population.  The items on the HADS focus on cognitive and emotional 
symptoms of anxiety and depression rather than somatic symptoms in order to reduce 
the potential confound with physical problems. This makes the HADS particularly 
useful when assessing psychological distress in people with physical health 
problems. Furthermore, the brevity of the measure also makes the HADS a useful 
measure where a number of measures are being used.  
The scale consists of 14 items: seven in the anxiety subscale (HADS-A), and seven 
in the depression subscale (HADS-D). Each item is scored on a scale from 0 to 3, 
with higher scores representing more severe symptoms. The test authors recommend 
that total subscale scores of 0-7 indicate sub-clinical levels of anxiety or depression; 
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8-10 mild cases; 11-15 moderate cases, and 16 or more indicating severe cases 
(Snaith & Zigmond, 1994; Zigmond & Snaith, 1983). A review by Bjelland et al. 
(2002) supports the use of 8 as a clinical cut-off.  
The HADS has been used widely, with the review by Bjelland and colleagues 
identifying 747 studies that referred to its use prior to May 2000. This review 
provided support for the two factor structure, with most studies identifying relatively 
independent dimensions of anxiety and depression closely related to HADS-A and 
HADS-D. Furthermore, the review supported the HADS‘ reliability and validity in 
primary care, as well as in hospital and community settings. The HADS was found to 
have reliable internal consistency, and good to very good concurrent validity when 
compared to other measures used to assess depression or anxiety, such as the Beck 
Depression Inventory (BDI) and the State Trait Anxiety Inventory (STAI). 
Correlations between the HADS-D and the BDI were 0.62 - 0.73 while those 
between the STAI and the HADS-A were 0.64 - 0.81.  
2.4.2. WHOQOL-BREF 
The World Health Organisation Quality of Life –  Brief Version (WHOQOL-BREF) 
(The WHOQOL Group, 1998a) was used to assess quality of life. The WHOQOL-
BREF has been used to measure quality of life in a number of recent studies of 
patients with medically unexplained symptoms (Sampalli et al., 2009), including 
irritable bowel syndrome (Barahmand, 2008), fibromyalgia (Haak & Scott, 2008), 
and chronic fatigue (Wang et al., 2009). 
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The scale, made up of 26 items, is an abbreviated version of the WHOQOL-100 
quality of life measure (The WHOQOL Group, 1998b) originally developed to 
produce a valid and reliable measure of quality of life. The WHOQOL-BREF, as 
with the WHOQOL-100, uses five-point Likert scales, and scores are produced on 
four domains: physical health; psychological health; social relationships, and 
environment. A global score, summarising two questions relating to overall quality 
of life and overall health satisfaction is also generated. Three questions are reverse 
scored. Each domain score is calculated by summing the appropriate items, then 
transforming it to a score between 0 and 100 to allow comparison across domains, 
with higher numbers indicating greater quality of life. Transformations were carried 
out in accordance with the WHOQOL-BREF manual (The WHOQOL Group, 1996). 
It has been suggested by one study that the reduced length of the WHOQOL-BREF, 
compared with the WHOQOL100, has led to a loss of sensitivity in the social domain 
(O'Carroll et al., 2000). Analysis by Skevington and colleagues (2004; Skevington & 
McCrate, 2012), however, found its validity and reliability to be satisfactory: internal 
reliability was found to be acceptable (>0.7) for physical, psychological and 
environment domains (0.82, 0.81, and 0.80, respectively), and marginal for the social 
domain (0.68); all subscales were able to discriminate between sick and well 
populations providing acceptable discriminant validity; and scores on the 
WHOQOL-BREF correlate highly (0.89 or greater) with those on the WHOQOL-100 
measure, showing good construct validity.  
   
62 
2.4.3. The 12-item somatic subscale of the Symptom Checklist 90 (SCL-
90-R) 
The SCL-90-R (Derogatis et al., 1976; Derogatis, 1977) is a symptom inventory 
measuring the intensity of self-reported somatic complaints over the past week. Each 
item is scored on a five-point Likert scale of distress (0-4) ranging from ‗not at all‘ to 
‗extremely‘, and scores are produced in nine primary symptom subscales.  
The 12-item somatisation subscale of the SCL-90-R was used to assess somatic 
symptoms experienced by participants. The subscale is made up of a list of twelve 
physical symptoms often reported alongside psychological problems. Mean scores 
are calculated resulting in scores ranging from 0-4.  
2.4.4. Philadelphia mindfulness scale 
The Philadelphia Mindfulness Scale (PHLMS) was used to measure mindfulness at 
pre- and post-intervention. Other mindfulness measures, including the Five Facet 
Mindfulness Questionnaire (FFMQ; Baer et al., 2006) and the Mindfulness Attention 
Awareness Scale (Brown & Ryan, 2003), were considered as alternative measures of 
mindfulness. Both scales were rated relatively highly in a recent systematic review of 
self-report mindfulness measures (Russell, 2011). The FFMQ was developed using 
exploratory factor analysis of five other mindfulness measures; it measures 
mindfulness as a multifaceted construct with five subscales, and as such would allow 
the exploration of the potential roles of specific aspects of mindfulness in patient 
outcomes. It is, however, a long measure with 39 items and it has not been validated 
with a clinical sample.  
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The reliability and validity of the MAAS is strong and it is shorter measure with only 
15 items, making it a more suitable length for this study. It is unclear, however, how 
far the MAAS can identify differences following a mindfulness-based intervention 
(Mackillop and Anderson, 2007). Furthermore, despite wide agreement in the 
literature that mindfulness is a multifaceted concept, mindfulness is measured as a 
single-factor on the MAAS. This conceptualisation of mindfulness does not fit with 
the definition by Bishop et al. (2004) as it does not assess acceptance towards that 
experience. 
The PHLMS was rated reasonably well in the systematic review of mindfulness 
measures (Russell, 2011). In terms of negative factors, the extent to which the 
PHLMS reflects differences in meditation experience has not been investigated, and 
the clinical groups used for validation were relatively small. The PHLMS is a 
relatively short measure, however, and the subscales allow investigation of the two 
key components of mindfulness proposed by Bishop and colleagues (2004).  
The PHLMS was considered to be the most appropriate measure for this study as it 
could be used to investigate the different aspects of mindfulness, and their role in 
patient outcomes, while not being restrictive in length.  It is a 20 item measure 
consisting of two factors (acceptance and present moment awareness) which are 
scored separately (Cardaciotto et al., 2008). A sample item from the awareness scale 
is ‗Whenever my emotions change, I am conscious of them immediately‘, and a 
sample item on the acceptance scale is ‗When I have a bad memory, I try to distract 
myself to make it go away‘. Items are rated on a 5-point scale (from ‗never‘=1 to 
‗very often‘=5), with items on the acceptance subscale being reverse scored. Total 
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scores on each subscale range from ten to fifty, with higher scores representing 
greater acceptance or awareness.  
Internal consistency and validity of the subscales was demonstrated by Cardaciotto 
and colleagues. They found that the acceptance and awareness subscales were not 
correlated, and as such that they be considered separate constituents of mindfulness 
and that they be examined separately. They also found that the subscales showed 
different relationships with other measures. While the awareness scale is related to 
more general mindfulness measures, the acceptance scale is not. Despite a small 
psychiatric sample which limited the conclusions that could be drawn regarding the 
subscales‘ relationships to psychopathology, higher levels of acceptance were found 
to be associated with lower levels of thought suppression, rumination, depression, 
and anxiety, suggesting that acceptance may be more important in improving mood 
than simply awareness. 
2.4.5. Additional measures 
In addition to the formal measures two questions were asked about the severity and 
frequency of symptoms. The first asked ‗How frequently have you experienced your 
symptoms over the last week?‘ Answers were on a 7-point Likert scale from 1 
(never) to 7 (always). The second asked ‗How severe have your symptoms been over 
the last week?‘ with answers also on a 7-point scale from 1 (None - no symptoms so 
no impact) to 7 (Very severe - cannot be ignored and markedly limits my daily 
activities). 
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2.5. Procedures 
2.5.1. Intervention development 
A focus group was carried out with a group of five GPs prior to the development of 
the self-help booklet. The GPs discussed the number of patients presenting with 
medically unexplained symptoms, the most frequent types of medically unexplained 
symptoms presented, and their thoughts on the benefits and difficulties of having a 
self-help booklet that could be offered to help patients manage such symptoms. 
Feedback from the GPs about having a self-help booklet to offer such patients was 
very positive, identifying it as an area where they would like more options to offer 
patients. They identified that the most frequent medically unexplained symptoms that 
they experienced in their clinics were irritable bowel syndrome (IBS), chronic 
fatigue (CF) and tension headaches.  
2.5.1.1. Intervention booklet and CD 
The intervention booklet was developed based on the mindfulness-based stress 
reduction (MBSR) programme designed by Jon Kabat-Zinn (1990). A clinical 
psychologist with over 15 years experience of mindfulness practice was involved in 
initial discussions about the booklet and in guiding its development alongside 
another psychologist experienced in mindfulness and in developing self-help 
booklets. They advised on its content, including the exercises and language used, to 
ensure that the booklet was consistent with an MBSR approach.  
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The final booklet (see Appendix 7) was a 32-page A5 booklet entitled ‗Helping you 
control your symptoms, instead of them controlling you: A mindful way towards 
managing physical symptoms‘. It included a front cover and contents page followed 
by an introductory section which consisted of short sub-sections on how to use the 
booklet; what mindfulness is; why it may be of use; tips for practice; and common 
frustrations. As participants were being given this as a pure self-help intervention, 
with no therapist involvement, the aim of this section was to try to provide 
information to participants about, and to engage them in, the intervention.  
The remainder of the booklet was based on Jon Kabat-Zinn‘s eight week 
Mindfulness-Based Stress Reduction (MBSR) group programme. The booklet was 
tailored towards MUS by making particular reference to how unpleasant or 
distressing symptoms or sensations might be incorporated into exercises, as seen in 
the ‗Staying with things that are difficult‘ section for example. Like the original 
programme, the self-help intervention followed an eight-week programme which was 
broken down into five steps. Each of the first three steps was to be carried out over 
two weeks each, and the final two steps one week each (see Table 2.1). Each step 
outlined the mindfulness practice to be carried out every day/week, and was followed 
by explanations of, or scripts for, the exercises. Prompts were also given to remind 
participants when tracks on the CD could be used. 
MBSR weekly sessions vary between groups but are generally made up of four core 
different types of mindfulness exercises: the body scan; focusing attention on the 
breath; practicing full awareness in everyday activities; and physical yoga exercises 
with a focus on awareness of the body. The first three elements were built into the 
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self-help intervention, however the physical exercises were not included following 
guidance from an experienced MBSR practitioner who advised that correct 
performance and participant safety could be jeopardised without an experienced 
member of staff present, as there would be in a group setting. 





Heading: Starting to become mindful 
- Carry out the One minute breathing exercise (page 9) at least once a 
day (but more often if you can).  
- Do the 10 minute Seated mindfulness exercise (page 10-11) with the 
attached CD or script every other day. 
- Choose one routine mindful activity in your daily life and make a 
deliberate effort to bring moment-to-moment awareness to that 
activity each time you do it. This could be brushing your teeth, 
having a shower or washing the dishes. 





Heading: Becoming aware of the pleasant 
- Continue doing the Seated mindfulness with the CD or script (page 
10-11) every other day.  
- On the days that you don‘t do the Seated mindfulness, carry out the 
Body scan with the attached CD or script (page 14-16). The idea is to 
―fall awake‖ rather than asleep. If you have trouble with sleepiness 
do it with your eyes open. 
- Practice the Three minute breathing space (page 17) once a day.  
- Pay attention to your experience of pleasant events over the next 
week and try to become aware of body sensations, thoughts and 
emotions occurring with the pleasant event. Simply focus in on 
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knowing what you are doing as you are actually doing it. 
- Choose another everyday activity to be your routine mindful activity, 




Heading: Increasing your mindful awareness 
- Continue to do the Seated mindfulness (pages 10-11) and Body scan 
exercise (page 14-16) on alternate days. If you have been doing these 
for about 10 minutes each until now, try to extend the length of time 
you spend practicing these to 20 minutes each day. 
- Introduce the Mindful eating exercise (page 20-21) and carry out one 
meal or snack mindfully each day. 
- Carry out the Turning towards the unpleasant exercise (page 22) 
three times per week.  
- Introduce mindfulness ―dots‖ into your life by placing stickers on 
objects in your immediate environment (e.g. on your computer, 
telephone, bathroom mirror, the key hole at your office door) and use 
them to act as triggers to remind you to take a breath and become 
more aware again.  
- Continue to apply the three minute breathing space when you are 
struggling with something. Apply the practice as a coping space for 




Heading: Staying with things that are difficult 
- Continue to do the Seated mindfulness exercise (page 10-11) and 
Body scan (pages 14-16) and on alternate days. If you have been 
using the CD for the Body scan, try doing it without the CD this 
week if possible. Try to increase the time that you spend doing these 
exercises. 
- Continue to eat one meal or snack a day mindfully (page 20-21). 
- Introduce a period of Mindful walking (page 25) everyday – this is 
best done when you are not in a rush to be somewhere! 
- Bring particular awareness to any experiences of difficulty arising 
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this week, and use periods of your formal practice to work with this. 
Notice when you find yourself getting caught up in thoughts about 
unpleasant sensations or symptoms and use the techniques practiced 
in the Turning towards the unpleasant exercise (page 22). 
- Continue to use the mindfulness ―dots‖ placed throughout your 
house/life to act as triggers to remind you to take a breath and come 




Heading: Your own mindful practice 
- Continue your mindful practice each day. During this week you can 
decide each day what is right for you to do from your experience of 
the exercises practiced over the past seven weeks.   
- Try the Loving kindness meditation (page 28). While some people 
can be put off by its name, many people find the exercise very 
helpful – calming the mind and body through cultivating compassion 
for yourself and others. 
- Read through the Mindfulness in everyday life section (page 29) and 
try to become more aware of what is happening and what you are 
doing throughout the day. 
- Consider ways that you will continue using the mindfulness practices 
you have been developing over the past eight weeks in day to day 
life.  
 
Each step included a page titled ‗My notes on step 1‘, for example, where 
participants were encouraged to note down when exercises were carried out and any 
comments following it (see Appendix 7).  
Seated mindfulness and Body scan exercise scripts were supplemented by audio 
tracks on an accompanying CD to help guide practice. The tracks were recorded by 
one of the psychologist guiding the intervention‘s development and he gave 
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permission for them to be used for the purposes of this research. Both tracks were 
approximately 30 minutes long, with a gong sounding every 10 minutes during the 
seated mindfulness track, signalling that participants could stop, to allow participants 
to build up their skill and experience gradually, particularly in early weeks.  
An overall Flesch readability score of 65 for the booklet was a calculated using Word 
2007, with sample sections ranging from 55.1 to 78.3, suggesting that the content 
should be easily understood by 13-15 year olds. Additionally, the booklet was 
assessed and passed by BISSY (Borders public Information Support Site for You), in 
NHS Borders, who ensure that materials produced by the health board are at an 
appropriate level of accessibility and readability for patients.  
Once the booklet was in final draft form, piloting was carried out with a focus group 
of staff -- including a nurse, occupational therapist, psychologist and support worker 
-- and non-staff. They gave feedback on usability, readability and size of the booklet. 
Feedback from the focus groups was incorporated into the final version of the 
booklet.   
2.5.2. Intervention evaluation 
Eight general practices from across NHS Borders were involved in the identification 
of potential participants for this project. The practices varied in location and socio-
economic area, as well as by size, ranging from a list size of around 3000, to around 
11,500.  GPs in each of the participating practices were given packs which included: 
a reminder sheet with the inclusion criteria on it; packs to offer patients who met the 
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criteria; an information sheet giving details of what to do if they had any questions or 
if they ran out of project information packs to give to patients. 
In most practices patients were identified by GPs as meeting the research criteria 
during routine appointments. GPs were given a guide script to introduce the research 
to patients who met the inclusion criteria: ‗One of our colleagues has developed a 
self-help intervention to help people manage symptoms such as yours, and is in the 
process of evaluating it. Would you be interested in being involved in the study?‘ 
GPs were, however, able to introduce the intervention as they felt appropriate, 
depending on the individual patient and their circumstances. Patients who were 
interested were given a pack to take away and look at in their own time. The pack 
included: an introduction letter (Appendix 6a); a participant information sheet 
(Appendix 6b); a consent form (Appendix 6c); a questionnaire booklet and a pre-paid 
addressed return envelope. Following an amendment to the project (for ethical 
approval and R&D approval see Appendix 8 and Appendix 9), one practice decided 
to identify patients who met the inclusion criteria through a database search of 
relevant diagnoses, and offered them inclusion in the project by sending them 
information packs by post. 
In the initial letter patients were invited to read through the information sheet and, if 
they were still interested in participating, to complete the consent form and 
questionnaire booklet and return them in the envelope provided. When packs were 
received each participant was given a project ID number. Identifiable patient 
information was stored separately in a locked filing cabinet and other data was given 
the appropriate ID number.  
   
72 
Participants were then sent the intervention booklet and CD alongside a covering 
letter asking them to follow the eight week programme outlined in the booklet. They 
were also told that they would be asked to complete questionnaires again after the 
eight week intervention. 
Post-intervention questionnaires were sent to all participants after eight weeks. 
Participants who did not return questionnaires within ten days were sent another 
questionnaire and return envelope, with a covering letter asking them to complete 
and return it if they had not already done so. Throughout the study, all participants 
continued with their usual medical care. A diagrammatic representation of participant 
recruitment and response can be seen in Figure 2.3.1. 
2.6. Power calculation 
A power analysis was carried out to calculate how many participants would be 
required to detect effects in the data. There is no available research in the area of 
mindfulness-based self-help with this population. A meta-analysis of a wide range of 
self-help interventions (Gould & Clum, 1993), in a mix of clinical and non-clinical 
populations, found an overall treatment effect size (d) of 0.76 at post-treatment. 
However, effect sizes varied widely depending on the presenting problem and 
population, and not all were psychological interventions. A recent meta-analysis of 
CBT-based guided self-help found effect sizes in clinical populations of 0.31 
compared to a mean effect size of 1.02 in media-recruited studies (Coull & Morris, 
2011). Due to the lack of research into the application of mindfulness, through self-
help, to this clinical population, a presumption was made that the effect size would 
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fall at the lower end of the spectrum shown in these meta-analyses. For this reason, a 
small-medium effect size was assumed.  
A power analysis using the G-Power 3.1.2 computer program (Faul et al., 2010) 
indicated that a total sample of 42 people would be needed to detect this small-
medium effect size (f =0.2) with 80% power using a repeated-measures ANOVA, 
with alpha at .05.  
An estimated attrition rate was based upon existing literature. Attrition rates of 33% 
and 35% have been found in an studies evaluating CBT for chronic fatigue of self-
help for patients with chronic fatigue (Friedberg & Sohl, 2009; Leone et al., 2006), 
while a rate of 16.6% was found in an RCT of generic self-help for patients with 
chronic fatigue (Chalder et al., 1997). Palmer and colleagues (2002) found an 
attrition rate of 25% in an RCT of self-help for bulimia, with 29% in the control 
group. To allow for an attrition rate at the higher end of this range an additional 
thirty-five percent was added to the indicated size giving a total planned baseline 
sample size of 57. 
2.7. Statistical analysis 
Analysis of the data was carried out using the statistical package SPSS (version 19 
for Windows). Primary analysis used the intention to treat principle, assuming return 
to baseline values for non-completers. Due to the high rate of attrition, additional 
analyses were carried out with the data from the sample that completed the post-
intervention measures, for exploratory purposes. Descriptive statistics were used to 
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investigate demographic information, looking at the sex, age, and type and duration 
of medically unexplained symptom reported.  
Exploratory data analysis was carried out to determine if the data met the 
assumptions of parametric statistical testing. Checks of skewness and kurtosis were 
carried out, and visual inspection of box-plots and histograms were used to assess 
normality. Discerning the shape of the histogram can be difficult with a small sample 
size, with the histogram changing significantly with changes in the interval width of 
the bars. For this reason, normal probability plots were inspected and the Shapiro-
Wilk test was also used to assess whether data was normally distributed.  
Parametric tests are more powerful than non-parametric tests (Dancey & Reidy, 
2007) and are robust to violations of their assumptions (Clark-Carter, 2004; Howell, 
2009), making them less likely to commit type II errors as a result (Clark-Carter, 
2004). Parametric tests are recommended if the data shows no clear 
contraindications, such as outliers, marked skewdness or great disparity of variances 
(Kinnear & Gray, 2009). Using such analyses was therefore considered appropriate, 
and the primary research questions were analysed using a series of repeated measures 
t-tests. For the secondary hypotheses, Pearson‘s correlations were used to evaluate 
the relationship between improvements in levels of mindfulness and improvements 
in outcome measures. Baseline comparisons of those who did and those who did not 
return post-intervention questionnaires (referred to as completers and non-completers 
respectively from here on) were carried out using independent t-test alongside 
Levene‘s test for homogeneity of variance. 
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Raw scores from the assessments, or transformed scores where this was outlined in 
administration and scoring guidelines for individual tests, were used to identify 
change in responses over the course of the intervention. 
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Abstract 
Background: Medically unexplained symptoms (MUS) can be as debilitating as 
those with a clear organic cause and are often associated with increased 
psychological distress and lower quality of life. Previous studies have found 
Mindfulness-Based Stress Reduction (MBSR) to be useful in improving anxiety, 
depression, symptom and quality of life in people with MUS. This study sought to 
evaluate a self-help MBSR intervention for this population. 
Methods: Participants with MUS (N=15) were introduced to the project by their GP 
during routine consultations. Psychological distress, symptoms, quality of life (QoL) 
and mindfulness were assessed prior to and following the eight week self-help 
MBSR intervention, and changes were evaluated using a within subjects design. In 
addition to the intention to treat group (ITT, N=15) analysis, those who completed 
post-intervention questionnaires (N=5) were evaluated separately for exploratory 
purposes.  
Results:  Reductions in symptom frequency were significant in the completer and 
ITT groups. Mean clinical improvements in anxiety and general and physical QoL 
were also observed in the completer sample, though changes were not statistically 
significant. Levels of mindful acceptance were found to improve significantly at 
post-intervention. 
Discussion: No firm conclusions can be drawn from this study, though 
improvements in the completer group suggest that further research would be 
warranted. The low levels of participation indicate that a greater understanding 
regarding the reasons for recruitment difficulties in this type of research would be 
beneficial. 
Key words: MBSR, self-help, chronic fatigue, fibromyalgia, irritable bowel 
syndrome. 
MUS = medically unexplained symptoms; GP = general practitioner; CBT = 
cognitive behaviour therapy; MBSR = mindfulness-based stress reduction; 
WHOQOL-BREF = World Health Organisation Quality of Life – Brief Version; 
QoL = quality of life; HADS = The Hospital Anxiety and Depression Scale; HADS-
a = HADS-anxiety subscale; HADS-d = HADS depression subscale; SCL-90-R = 
The Symptom Checklist 90; PHMLS = The Philadelphia Mindfulness Scale; CD = 
compact disc; SD = standard deviation; ITT = intention to treat; 
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3.1. Introduction 
Medically unexplained symptoms (MUS), physical symptoms where no organic 
pathology can be identified following investigation, have a considerable impact on 
individuals and the healthcare system. Symptoms can include pain, weakness or 
fatigue, and many medical specialisms have developed diagnostic categories for 
MUS such as irritable bowel syndrome (gastroenterology), fibromyalgia 
(rheumatology) and chronic fatigue (1). Patients presenting with MUS can 
experience pain, distress, discomfort and disability comparable to that caused by 
identifiable disease (2-4). They also visit their GP often, with prevalence estimates 
suggesting that they account for around a third of hospital outpatient referrals (5) and 
between 15 and 30% of patients in primary care (2, 6). In addition, resources are 
often wasted on ineffective attempts at treatment (7, 8) resulting in significant costs 
to the NHS and the potential to cause harm and discomfort to the patient through 
non-essential surgery or investigation (9).  
Evidence suggests that a high proportion of patients with MUS experience 
psychological distress. In their study of cognitive behavioural therapy (CBT) for 
MUS, Bleichhardt and colleagues (10) found that 74% of their subjects had comorbid 
affective disorders and 47% had comorbid anxiety disorders. Another study (11) 
found that 63% of patients with MUS had comorbid major depressive disorder. 
Sharpe (12) proposes that undiagnosed depression is one of the greatest causes of 
MUS, suggesting that physical symptoms such as fatigue, weight-loss and 
complaints of pain are misdiagnosed, or go undiagnosed, due to the erroneous belief 
that depression is solely a mental health problem. For similar reasons he suggests 
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that anxiety and panic are also common causes of MUS. Continuing stigma in 
Western societies toward mental health may increase the likelihood of psychological 
distress being manifested somatically. It has also been identified that the distress 
caused by these symptoms can lead to anxiety or depression, which in turn serves to 
worsen symptoms (13). Such self-perpetuating circles - where physical symptoms 
lead to poorer psychological wellbeing, which in turn worsens symptoms - are 
recognised in many chronic health conditions (14, 15). 
Several psychological therapies have been introduced to this population to help 
manage distress. However, a difficulty for the psychological treatment of MUS is 
that people often believe that their problems are either purely physical or purely 
psychological (1). So while there is evidence that cognitive behavioural therapy can 
be beneficial for some patients with MUS (16-18), many patients interpret a referral 
to a psychologist, or for the thought-challenging exercises typical of CBT, as a 
rejection or denial of their problems as being real, or feel that they are being told that 
it is ―all in their head‖. Stone and colleagues found that psychological-sounding 
diagnostic labels often appear offensive to patients who preferred terms such as 
‗stress-related‘ (19). 
Mindfulness-Based Stress Reduction (MBSR) is traditionally a standardised group 
therapy which evolved from the integration of Buddhist meditation into western 
psychological and clinical practice, and was developed by Jon Kabat-Zinn (20). 
Growing evidence indicates that MBSR can improve coping and quality of life 
(QoL) in many chronic conditions, including cancer (21, 22) and chronic pain (23, 
24), and in mental health problems it has been shown to reduce anxiety, depression 
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and stress (25-27). Methodologically rigorous studies investigating the effectiveness 
of MBSR for MUS such as IBS and fibromyalgia, have shown positive changes in 
psychological distress, symptoms and QoL (28, 29). MBSR therefore provides an 
alternative, and potentially less threatening, stress reduction approach to dealing with 
unexplained symptoms. 
Unlike traditional CBT, mindfulness therapies sit within the ―third wave‖ of 
cognitive behaviour therapies which work from a more acceptance-based stance. As 
a result the focus of MBSR is not upon changing unhelpful thinking, but on changing 
the process by which symptoms are experienced. A two-component model of 
mindfulness has been defined by Bishop et al. (30). 
The first component involves the self-regulation of attention so that it is 
maintained on immediate experience, thereby allowing for increased 
recognition of mental events in the present moment. The second 
component involves adopting a particular orientation toward one’s 
experiences in the present moment, an orientation that is characterized 
by curiosity, openness, and acceptance.’ (p232).  
In this way, mindfulness includes attending to negative physical sensations or 
distressing thoughts or images when these occur, in contrast with the avoidance or 
distraction that is often used as means of coping with these distressing experiences.  
It has been proposed that while avoidance and distraction can be useful in response 
to temporary stresses, they become maladaptive when used for long term pain, 
discomfort or distress (31), and evidence suggests that thought suppression and 
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avoidant coping generally predict poorer long-term outcome (32). This reduction in 
avoidance and reactivity to symptoms and cognitions allow for exposure to, and 
acceptance of, the experiences (33, 34), reducing negative affect and potentially 
improving  psychological health (35). 
Given the large numbers of people presenting to their GP with MUS, small 
improvements in physical or psychological wellbeing, or quality of life, in this 
population have the potential not only to improve people‘s lives, but also to have a 
beneficial economic impact on health services. As a result of the difficulties 
experienced by patients with MUS, and the frustration that GPs experience due to a 
perceived lack of effective treatment options (36), an MBSR-based self-help 
intervention has been developed as a means of reaching patients who may otherwise 
not have access to, or the inclination to accept, direct psychological input. There 
have been no evaluations of self-help MBSR for such symptoms to date.  
This study evaluates a pilot of the self-help MBSR intervention, investigating its 
impact on psychological distress, symptoms, mindfulness and QoL, with the 
hypothesis that these outcomes would improve following the intervention.  
3.2. Method 
3.2.1. Participants 
Eight Scottish NHS medical practices were involved in the recruitment of 
participants. GPs were responsible for identifying and introducing the project to 
potential participants. Inclusion criteria for the project were adult patients with a 
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diagnosis of IBS, chronic fatigue, tension headaches or fibromyalgia; their GP 
determined that they had undergone appropriate investigation of their symptoms, and 
that there was no known medical basis or partial basis for the symptoms. Participants 
also needed to have sufficient understanding of the English language to complete 
standardised forms. 
Patients who met these inclusion criteria were introduced to the project by their GP 
who gave them a project information pack to read, complete and return to the 
investigator if they decided to participate. Those who completed and returned the 
enclosed consent form and questionnaire were considered participants. This resulted 
in 15 patients, between the ages of 22 and 65, being recruited as project participants. 
3.2.2. Procedure 
Participants completed the questionnaire booklet at baseline. Once this had been 
returned they were sent the intervention booklet and CD, and eight weeks later they 
were sent a post-intervention questionnaire. The baseline questionnaire booklet asked 
participants for their age, sex, main symptom, and length of time they had 
experienced their symptoms. Participants who did not return the post-intervention 
questionnaire within ten days were sent a reminder letter asking them to complete 
and return the enclosed questionnaire. The following outcome and process measures 
were included in the questionnaire booklet: 
3.2.2.1. Psychological distress 
The Hospital Anxiety and Depression Scale (HADS) was used to measure 
psychological distress (37). The HADS is a self-report measure which was initially 
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designed for use with physically ill patients, and as a result somatic symptoms were 
excluded to avoid potential confounding by physical problems. The scale consists of 
14 items: seven for anxiety (HADS-a) and seven for depression (HADS-d); each 
scored 0-3 with higher scores representing more severe symptoms. Subscale scores 
of 0-7 are considered ―normal‖, while scores of eight or above are considered cases 
of anxiety or depression (38, 39).   A review by Bjelland and colleagues provides 
support for its reliability and validity in primary care, as well as in hospital and 
community settings (39).   
3.2.2.2.  Quality of life (QoL) 
The World Health Organisation Quality of Life – Brief Version (WHOQOL-BREF) 
(40) was used to assess quality of life. This 26 item scale is an abbreviated version of 
the WHOQOL-100. Five point Likert scales are used, and scores are produced on 
four domains: Physical health; Psychological health; Social relationships, and 
Environment. These scores are transformed to a scale of 0-100 making them 
comparable across domains. Two questions, relating to overall QoL and overall 
health satisfaction, are summed to produce a ‗General‘ score between 2 and 10. 
Scores on the WHOQOL-BREF correlate highly (0.89 or greater) with those on the 
WHOQOL-100 measure. The WHOQOL-BREF has good to excellent reliability and 
performs well in tests of validity (41).  
3.2.2.3. Symptoms 
The Symptom Checklist 90 (SCL-90-R) (42, 43) is a symptom inventory. Somatic 
symptoms experienced by participants were assessed using the 12-item somatisation 
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subscale of the SCL-90-R, consisting of a list of physical symptoms often reported 
alongside psychological problems. Participants were asked how much each problem 
has bothered or distressed them, scoring each on a five-point Likert scale (from ―not 
all all‖ = 0, to ―extremely‖ = 4). Two additional questions, scored on a seven-point 
Likert scale, relating to symptom severity and symptom frequency were also 
included. 
3.2.2.4. Philadelphia mindfulness scale 
The Philadelphia Mindfulness Scale (PHMLS) (44) is a 20 item measure of two 
factors: acceptance, and present moment awareness. These factors are scored 
separately. Items are rated on a 5-point scale (from ―Never‖=1 to ―Very often‖=5).  
Total scores on each subscale range from ten to fifty, with higher scores representing 
greater acceptance or awareness. Internal consistency and validity of the subscales 
was demonstrated by Cardaciotto and colleagues (44).  
3.2.3. Intervention 
Participants were each given a 32-page, A5, self-help intervention booklet and 
accompanying audio CD, entitled ―Helping you control your symptoms, instead of 
them controlling you: A mindful way towards managing physical symptoms”. The 
booklet and CD were based on the mindfulness-based stress reduction (MBSR) 
programme designed by Jon Kabat-Zinn (20) (for the development of this booklet 
see Methods section 2.5.1). The booklet included short sub-sections on: how to use 
the booklet; what mindfulness is; why it may be of use; tips for practice; and 
common frustrations. These sections included an explanation of why MBSR was 
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considered beneficial for people with symptoms without  a clear medical cause, as 
well as for those with symptoms which do. As participants were being given this as a 
pure self-help intervention with no therapist involvement, the aim of these sections 
was to provide a rational and to engage them in the intervention.  
The remainder of the booklet was based on Jon Kabat-Zinn‘s eight week 
Mindfulness-Based Stress Reduction (MBSR) group programme. The booklet was 
tailored towards MUS, for example by making reference to how exercises might 
relate to symptoms or sensations in the ‗Staying with things that are difficult‘ 
section. Like the original MBSR programme, the current self-help intervention 
followed an eight-week programme which was broken down into five steps. The first 
three steps were carried out for two weeks each, and the final two steps one week 
each. Each step outlined the mindfulness practice to be carried out every day/week, 
and was followed by details for the mindfulness exercises. Prompts were also given 
to remind participants when tracks on the CD could be used. 
Physical yoga exercises usually included in MBSR group interventions were not 
included following guidance from an experienced MBSR practitioner who advised 
that correct performance, and participant safety, could be jeopardised without an 
experienced member of staff present (a staff member would be present in a group 
setting). 
3.2.4. Statistical analysis 
Exploratory data analysis was carried out to check that the data met the assumptions 
required for parametric statistics. Baseline comparisons of those who did and those 
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who did not return post-intervention questionnaires (referred to as completers and 
non-completers respectively from here on) were carried out using independent t-test 
alongside Levene‘s test for equality of variance. Following the exploratory analysis 
of the data and consideration of the design of the study and hypotheses being tested, 
the primary research questions were analysed by a series of repeated measures t-tests.  
As data for non-completers was limited to that gained at baseline, intention to treat 
(ITT) principals were followed for primary analyses, using the last observation 
carried forward method, imputing data from baseline at post-intervention. Due to the 
small sample size and relatively high attrition rate, analysis of data solely from the 
completer sample was also carried out. There are limitations to what can be inferred 
from the results of such a small sample, however the analyses were carried out for 
exploratory purposes with a view to guiding further investigations in this area rather 
than producing conclusive evidence. 
3.3. Results 
Five of the fifteen participants who were sent the self-help intervention booklet 
completed and returned the post-intervention questionnaires, while ten did not, 
giving an attrition rate of 67%.  
3.3.1. Demographic Information  
The clinical population considered in this study was a mixed sample of individuals 
with different types of medically unexplained symptoms. The 15 participants 
involved in this study came from five of the eight practices that agreed to take part in 
recruitment. Participants were aged between 22 and 65 years, with a mean age of 
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38.9 (SD = 11.9). Of these, four-fifths were female, and all of those who completed 
the intervention were female. In terms of primary diagnosis, nine participants had 
IBS (60%); four had chronic fatigue (27%); one  had fibromyalgia (7%) and one 
tension headaches (7%). Of those who completed and returned post-intervention 
questionnaires, two had IBS, two had chronic fatigue and one had fibromyalgia.  
The length of time that participants had experienced their symptoms ranged from one 
month to thirty years (M = 8.1 years , SD = 8.77).  Three of the participants who 
returned post-intervention questionnaires reported that they followed the eight week 
intervention completely and one completed it ―somewhat‖. One participant did not 
complete this section. 
3.3.2. Baseline comparisons of completer and non-completer groups 
Baseline data for non-completers was compared with that of the completer group 
(see Table 3.1). The only area in which scores differed significantly at baseline was 
on the social subscale of the WHOQOL-BREF, with the completer sample showing 
significantly better social QoL than the non-completers (p =.016). Differences in 
duration of symptoms appear marked, with the completer sample showing a mean 
duration of over 16 years compared with over five years in the non-completers. 
However, as variances were significantly different (F = 7.73, p = .017), the mean 
difference between the groups was non-significant (p =.105).  
Though differences in anxiety and depression were not statistically significant, 
clinically relevant differences were also considered. When comparing mean scores 
against clinical cut-off scores for caseness of anxiety and depression on the HADS 
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(39) the completer group fell below the cut-off  of 8 for anxiety, while the non-
completer sample fell within the mild to moderate range. The completer sample also 
showed sub-clinical levels of depression, while the non-completer group scored 
above the clinical cut-off again. None of the completers fell in the moderate or severe 
range of HADS scores for either anxiety or depression at baseline, compared with the 
non-completer group where six participants (60%) fell into this range for anxiety, 
and four (40%) for depression.  
In addition, though differences were not significant, the completer sample showed 
lower mean symptom scores and higher quality of life scores than the non-completer 
sample on all sub-scales. The only area where non-completers performed better then 
completers at baseline was on the awareness subscale of the PHLMS mindfulness 
measure.  
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3.3.3. Primary analyses 
Analyses of change in outcome measures between pre- and post-intervention were 
carried out using paired t-tests. Means and standard deviations, in addition to p-
values and effect sizes (Cohen’s d), are reported for the ITT sample (Table 3.2) and 
for the completer sample (Table 3.3). Effects on psychological distress, symptoms 
and QoL are considered in the following sections. 
3.3.3.1. Effects on psychological distress 
Reductions in mean depression scores were observed in the ITT and completer 
groups, however the changes were not statistically significant (see Table 3.2 and 
Table 3.3). Mean anxiety scores were found to reduce and, while the changes were 
also non-significant, the reduction took mean HADS-a scores for the completer 
sample clearly below the clinical cut-off.  
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Table 3.2  Changes in psychological distress, symptoms and QoL between 
pre- and post-intervention in the ITT group (N=15) 
 Pre-intervention Post-intervention    




       
HADS-d 8.00 4.00 7.80 4.00 0.676 .510 0.07 
HADS-a 9.73 3.94 9.27 4.37 1.705 .110 0.11 
Symptoms        
SCL-90-R  1.68 0.68 1.53 0.72 2.442 .281 0.07 
Symptom 
frequency  
6.00 0.76 5.27 1.28 1.710 .028 0.33 
Symptom 
severity 
5.27 1.22 5.07 1.39 1.146 .271 0.04 
Quality of Life 
(QoL) 
       
WHOQOL-
BREF General † 
5.20 1.42 5.60 1.19 -1.468 .164 0.20 
WHOQOL-
BREF Physical  † 
38.87 15.20 43.87 17.63 -1.714 .109 0.21 
WHOQOL-
BREF Psych † 
51.33 16.60 52.13 16.51 -0.652 .525 0.05 
WHOQOL-
BREF Social † 




63.33 19.40 62.40 18.70 1.080 .299 0.05 
† Indicates measures where an increase in mean score represents a better outcome 
HADS: Hospital Anxiety and Distress Scale; SCL-90-R: Symptom Checklist 90 Revised; WHOQOL-
BREF: World Health Organisation Quality of Life – Brief Version 
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Table 3.3  Changes in psychological distress, symptoms and QoL between 
pre- and post-intervention in the completer sample (N=5) 
 Pre-intervention Post-intervention    




       
HADS-d 6.00 3.00 5.40 2.40 0.647 .553 0.19 
HADS-a 7.40 1.95 6.00 2.55 2.064 .108 0.54 
Symptoms        
SCL-90-R  1.62 0.56 1.18 0.56 1.146 .316 0.68 
Symptom 
frequency  
5.60 0.55 3.40 0.55 5.880 .004 3.49 
Symptom 
severity 
4.75 1.26 4.33 1.53 1.177 .305 0.26 
Quality of Life 
(QoL) 
       
WHOQOL-BREF 
General † 
5.60 0.55 6.80 2.08 -1.633 .178 0.68 
WHOQOL-BREF 
Physical † 
43.80 19.31 58.80 16.69 -2.082 .106 0.72 
WHOQOL-BREF 
Psych † 
58.80 10.52 61.20 7.12 -0.623 .567 0.23 
WHOQOL-BREF 
Social † 
82.00 14.08 75.00 15.98 1.486 .212 0.40 
WHOQOL-BREF 
Environmental † 
76.40 13.80 73.60 13.45 1.095 .335 0.18 
† Indicates measures where an increase in mean score represents a better outcome 
HADS: Hospital Anxiety and Distress Scale; SCL-90-R: Symptom Checklist 90 Revised; WHOQOL-
BREF: World Health Organisation Quality of Life – Brief Version 
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3.3.3.2. Effects on symptoms 
Improvements observed on the SCL-90-R somatic subscale and symptoms severity 
were not  significant in either the ITT or completer groups.  
Changes observed in symptom frequency were, however, significantly improved at 
post-intervention both in the completer sample and the ITT group (p =.004 and p 
=.028, respectively). A large effect was identified for the completer sample and a 
small effect for the ITT group (d = 3.49 and d = 0.33, respectively). In terms of 
clinical meaning, the changes in scores in the completer sample related to 
participants experiencing symptoms ‗most of the time‘ at baseline and ‗occasionally‘ 
at post-intervention. 
3.3.3.3. Effects on quality of life (QoL) 
The completer sample showed two standard deviations of mean change, in the 
anticipated direction, on the WHOQOL-BREF ‗General‘ subscale. However, these 
changes were not statistically significant.  
Mean changes in score on the physical QoL subscale were in the anticipated 
direction at post-intervention, with almost one standard deviation difference, 
however these changes were also not statistically significant.  
3.3.4. Secondary analysis 
Mindfulness was hypothesised to increase at post-intervention. Analyses of change in 
mindfulness between pre- and post-intervention were carried out using paired t-tests. 
Awareness and acceptance subscales were considered separately, and completer 
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sample analyses were once again carried out in addition to the ITT analyses for 
exploratory purposes.  
3.3.4.1. Effects on awareness 
Mean post-intervention scores on the awareness subscale of the PHLMS remained 
similar to baseline scores for both the ITT and completer samples (as seen in Figure 
3.3.1.)  Neither the ITT nor the completer sample showed significant changes (t =-
.289, p =.777; and t =-.268, p =.801, respectively.) 
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3.3.4.2. Effects on acceptance 
Mean levels of acceptance were found to improve at post-intervention in both the 
ITT and completer samples, as seen in Figure 3.3.2. These changes in acceptance 
were found to be significant both for the ITT sample (t =-2.143, p =.05) and the 
completer sample (t =-3.384,  p =.028). Effect sizes were small in the ITT sample 
and small-medium in the completer sample (d = 0.16 and d = 0.36, respectively.) 




As this was a within-subjects study of a small sample, no firm conclusions can be 
drawn from the findings. The value of the findings is largely in their utility in future 
research, guiding hypotheses and informing study design and recruitment planning.  
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3.4.1. General outcomes 
Symptom frequency reduced following the intervention, not only for the completer 
sample, but also for the more conservative ITT group. Though the results are 
restricted by the small sample size, limiting their generalisability, they suggest that 
self-help MBSR may reduce reported symptom frequency in patients with MUS.   
None of the other outcome improvements observed were significant in either the 
completer sample or ITT group, meaning that the hypotheses that participants who 
carried out the MBSR intervention would show improvements in psychological 
distress and QoL are not supported. Given the small number of subjects this is 
unsurprising. However, while these changes were non-significant, eight out of the ten 
measures changed in the anticipated direction at post-intervention, showing enough 
promise to warrant future research.  
Only social and environmental QoL showed a change in the opposite direction to 
what was expected at post-intervention, and these were also not significant. Though 
QoL was expected to increase following completion of the intervention, social and 
environmental areas of QoL were not targeted in this intervention so it is 
unsurprising that no improvement was observed in this area.  
Without a control group or long-term follow-up it is impossible to determine if the 
changes observed were due to the intervention, rather than involvement in the study, 
natural improvement over time, or other issues such as chance or measurement 
limitations. Participants‘ symptoms had existed for a mean duration of around eight 
years prior to the intervention. So, while it may be considered unlikely that 
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spontaneous improvement in symptoms occurred during the course of the 
intervention, the lack of follow-up assessment means that the possibility that changes 
could be due to natural fluctuations in symptoms cannot be ruled out.  
The attrition rate was high for this study, which was not entirely unanticipated. A 
combination of issues are likely to have contributed to this, including that  the 
intervention was self-help based and as such required a reasonable level of 
motivation and self-efficacy, which are commonly impaired in people with 
depression. As the non-completer group showed more clinically relevant levels of 
depression than the completers it is possible that this impacted upon attrition rates. 
Secondly, the focus of the intervention was on patients managing symptoms rather 
than eradicating or curing them, which some participants may have found difficult. 
Thirdly, the intervention uses techniques that people may find hard to put into 
practice, particularly on their own. These factors may have contributed towards the 
high attrition rates observed in addition to the fact that high attrition rates are not 
uncommon in participants with MUS (45, 46). 
Whilst levels of awareness did not improve following the intervention, levels of 
acceptance improved significantly. Levels of awareness amongst participants 
appeared to be relatively high at baseline. Mean scores were comparable with non-
clinical samples found in previous research, whilst levels of acceptance were lower 
than other clinical samples (44). It is possible that the non-judgemental, experiential 
nature of MBSR in relation to negative experiences may have led to an increase in 
levels of acceptance. Again these findings are limited by the sample size, however as 
it is acceptance rather than awareness that is thought to impact most on psychological 
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wellbeing (44), these finding provide optimism for the possibility of MBSR being 
carried out by some patients in this self-help format. 
3.4.2. Limitations of the study 
Recruitment to the project was considerably lower than anticipated, and in spite of 
repeated efforts to adapt the project to improve this (see Chapter 5.3), numbers 
remained small. In addition to difficulties recruiting, a high level of attrition led to 
particularly small number of completers, making conclusions about the effectiveness 
of the intervention very difficult.  
The majority of potential participants did not engage in the study, and there appear to 
be notable differences between those who completed the intervention and those who 
did not. As a result the representativeness of the sample is limited, adding to the 
difficulty generalising findings.  
The lack of a control group also limits this study as it meant that changes could not 
be compared to a non-active or alternative therapy group, preventing such changes 
from being definitively attributed to the intervention.  
3.4.3. Strengths of the study 
The study attempted to evaluate a newly developed intervention, targeting an area in 
which both GPs and patients identify there to be a lack of effective treatment options 
(47). It attempted to implement and evaluate the intervention in a context as close to 
clinical reality as possible, in a bid to provide ecologically valid findings which 
could be easily transferred to practice. While this appears to have made recruitment 
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difficult, the study did recruit a clinical sample in a clinical setting. As other studies 
have identified, evaluating clinical samples can produce different, often less 
impressive, results to a non-clinical, or self-selecting sample (48).  
In addition, unlike some studies where those who dropped out after receiving a 
detailed description of the intervention are not included as participants (49), this 
study considered everyone who completed baseline measures as participants. So 
while it experienced greater attrition rates than other studies, it demonstrated greater 
ecological validity.  
3.4.4. Implications 
The findings presented here do not provide generalisable evidence of the 
effectiveness of this self-help MBSR intervention for patients presenting to their GP 
with MUS. However, the improvements in symptom frequency and levels of 
acceptance suggest that more research is warranted in this area. Larger, suitably 
powered studies are needed in order for conclusions to be drawn about the 
effectiveness of the intervention for people with MUS. Future studies would also 
benefit from both treatment-as-usual and active controls. The controls would help to 
determine whether changes were attributable to the MBSR intervention, rather than 
involvement in study or natural improvement over time. In addition, as gains made 
over the course of MBSR have been found to continue to improve following 
completion of the intervention (28), sometimes with non-significant changes 
becoming significant at follow-up (50),  the inclusion of a follow-up stage of 
assessment would also improve future studies. This would help to identify if a 
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similar pattern of  continued improvement is observed following the use of a self-
help MBSR intervention.  
A better understanding of the difficulties recruiting patients to this type of study 
would be beneficial. One option would be to carry out interviews with a sample of 
GPs, exploring themes that arise with regard to recruitment issues. Another option 
would be to identify factors which could explain some of the difficulty experienced 
recruiting participants through the use of a questionnaire survey to participating GPs.  
3.5. Conclusions 
Due to the small sample, the findings of this study are unable to determine whether  
the self-help MBSR intervention is effective in improving psychological distress, 
symptoms or QoL, however the positive changes observed suggest that further 
investigation in this area is merited. Such research would benefit from a much larger 
sample size, as well as control groups and a follow-up stage. Further exploration of 
some of the difficulties experienced recruiting participants to this type of study could 
help to avoid similar difficulties being experienced, allowing larger samples to be 
recruited. 
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4. Additional Results 
This study investigated the effectiveness of a self-help MBSR intervention in 
improving participants‘ symptoms, mood, and quality of life. Each participant was 
assessed prior to and following the eight week intervention.  
Demographic information, and information about baseline differences between 
completer and ITT groups were considered in the journal article results section (see 
Chapter 3.3) and will not be repeated here. The following sections outline the testing 
of each of the study‘s hypotheses. The next section outlines the changes that each 
individual participant who completed the intervention made between pre- to post-
intervention. This is followed by a summary of participant feedback on the 
intervention. 
4.1. Hypothesis testing 
Three main hypotheses were:  
Hypothesis 1: Participants with MUS who carry out the self-help based 
MBSR intervention will show improvements in symptoms, psychological 
distress and quality of life at post-intervention. 
Results in relation to Hypothesis 1 are covered in the journal article, Chapter 3.3, and 
as such are not duplicated here.   
Hypothesis 2: Levels of mindfulness will be improved following completion 
of the MBSR intervention. 
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Results in relation to Hypothesis 2 are covered in the journal article, Chapter 3.3.4, 
and as such are not duplicated here.   
Hypothesis 3: There will be an association between improvements in levels 
of mindfulness, particularly levels of acceptance, and improvements in 
symptoms, psychological distress and quality of life. 
Correlations were conducted to investigate if any relationship existed between 
improvements in participants‘ outcome scores and improvements in their scores on 
the mindfulness subscales of awareness and acceptance. Scores were calculated by 
subtracting outcome scores gained at baseline from those at post-intervention. This 
same calculation was carried out for the acceptance and awareness subscale scores. 
Correlations were only carried out in the completer sample as comparing change 
scores of zero with other change scores of zero would result in erroneously greater 
correlations (as would be the case in the ITT group where the last observation carried 
forward method was used).  
As the data fulfilled the assumptions for parametric statistics Pearson‘s correlations 
were used. The level of significance was based on a two-tailed test at the 0.05 level.  
4.1.1. Hypothesis 3.1: Improvements in outcome measure are 
associated with increased Awareness 
Correlations between changes in the mindfulness subscale of Awareness and changes 
in outcome measures can be seen in Table 4.1. 
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Table 4.1  Correlations of change in outcome measures with change in 
Awareness in the completer sample 
Change scores in Pearson’s r p 
Psychological distress   
HADS-d* -.247 .689 
HADS-a* .040 .949 
Symptoms   




Symptom severity* .696 .192 
















* Indicates measures where a negative correlation represents improvement on an 
outcome measure being associated with improvements in Awareness. 
† Indicates measures where a positive correlation represents improvements on an 
outcome being associated with improvements in Awareness. 
4.1.1.1. Hypothesis 3.1.1: Psychological distress 
No significant correlation was found between changes in Awareness and either 
changes in depression or anxiety at post-intervention.  
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4.1.1.2. Hypothesis 3.1.2: Symptoms 
A significant correlation was identified between changes on the SCL-90-R somatic 
symptom subscale and changes on the mindfulness subscale of Awareness (r =.894, 
p= .041). The correlations shows a relationship between increased awareness and 
increased somatic symptom score. 
There was no significant correlation associating changes in symptom frequency or 
symptom severity with changes in Awareness.  
4.1.1.3. Hypothesis 3.1.3: Quality of Life 
Changes on the awareness subscale were not found to significantly correlate with 
changes in WHOQOL-BREF subscales.  
4.1.2. Hypothesis 3.2: Improvements in outcome measure are 
associated with increased Acceptance 
Correlations between changes in the mindfulness subscale of Acceptance and 
changes in outcome measures were carried out and can be seen in Table 4.2. 
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Table 4.2  Correlations of change in outcome measures with change in 
Acceptance in the completer sample 
Change scores in Pearson’s r p 
Psychological distress   
HADS-d* -.582 .303 
HADS-a* -.024 .970 
Symptoms   




Symptom severity* -.032 .960 
















*Indicates measures where a negative correlation represents improvement on an 
outcome measure being associated with improvements in Acceptance. 
† Indicates measures where a positive correlation represents improvements on an 
outcome being associated with improvements in Acceptance. 
4.1.2.1. Hypothesis 3.2.1: Psychological distress 
No significant relationship was found between changes in levels of Acceptance and 
changes in levels of anxiety or depression.  
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4.1.2.2. Hypothesis 3.2.2: Symptoms 
There was no significant relationships between change in symptom scores and 
changes in levels of Acceptance.  
4.1.2.3. Hypothesis 3.2.3: Quality of Life 
Changes on the WHOQOL-BREF subscales, and general QoL score, did not 
significantly correlate with changes in Acceptance. 
4.2. Outcomes by participant 
The following section outlines the outcomes for each individual participant who 
completed the intervention. Graphs show changes in outcome for the individual 
participants and reliable change index scores and clinically significant change index 
scores have been calculated where possible. 
The reliable change index was a concept introduced by Jacobson and colleagues 
(1984) and developed further by Jacobson & Traux (1991). It provides a measure of 
statistical and clinical significance, taking into account scale reliability. A reliable 
change index score (RCI) of 1.96 or greater, in either direction, is considered 
statistically reliable at the 95% confidence level (Jacobson & Traux, 1991). RCI 
scores were calculated for each of the measures where test-retest reliability 
information was available. The concept of clinical significance was also introduced 
by Jacobsen and colleagues (1984) and relates to whether change experienced takes 
the person from a score typical of problem or clinical difficulties to a score typical of 
the "normal" population. Depending on the information that is available Jacobsen 
and Traux (1991) offer different methods of calculating clinical significance. Their 
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methods were used to calculate clinical significance and, where possible, they were 
calculated using both clinical and normative data. 
4.2.1. Participant 1 
4.2.1.1. Symptoms 
Figure 4.2.1   Participant 1:  Pre- and post-intervention scores on symptom 
measures 
 
Participant 1 had an RCI of 3.53 on the SCL-90-R somatic symptom subscale, 
suggesting that the change observed (see Figure 4.2.1) is unlikely to be due to simple 
measurement unreliability. In addition, the changes were clinically significant with a 
score typical of the non-clinical population at post-intervention. Changes in symptom 
frequency were clinically significant, when analysed using clinical distribution, 
though reliable change could not be calculated. 
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4.2.1.2. Psychological distress 
Figure 4.2.2   Participant 1:  Pre- and post-intervention scores on HADS 
anxiety and depression scales  
 
The change in level of anxiety from pre- to post-intervention (see Figure 4.2.2) had 
an RCI of 2.56, suggesting significance at the 95% confidence level. The 
participant‘s levels of anxiety were already below the cut-off for clinical significance 
at pre-intervention. Reliable and clinical changes were not significant when 
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4.2.1.3. Quality of Life 
Figure 4.2.3  Participant 1:  General quality of life at pre- and post-intervention  
 
Improvement in general quality of life (see Figure 4.2.3) was clinically significant 
for participant 1 however an RCI cannot be calculated so there is no measure of 
reliable change. None of the changes on the domains of quality of life (see Figure 
4.2.4) were significant using the criteria for reliable change. 
Figure 4.2.4   Participant 1: Quality of life domains at pre- and post-
intervention  
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4.2.1.4. Awareness & Acceptance 
Figure 4.2.5   Participant 1: Awareness and Acceptance at pre- and post-
intervention  
 
There was no significant change (see Figure 4.2.5) in Awareness or Acceptance 
using the reliable change index in participant 1. 
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4.2.2. Participant 2 
4.2.2.1. Symptoms 
Figure 4.2.6   Participant 2:  Pre- and post-intervention scores on symptom 
measures  
 
Changes in frequency at post-intervention (see Figure 4.2.6) were clinically 
significant for participant 1 using the clinical distribution; changes in severity were 
not. There was no change on the somatic symptom subscale of the SCL-90-R. 
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4.2.2.2. Psychological distress 
Figure 4.2.7   Participant 2:  Pre- and post-intervention scores on HADS 
anxiety and depression scales   
 
While change on the anxiety domain of the HADS (see Figure 4.2.7) was significant 
using the reliable change index (RCI = 2.56) it did not meet the criteria for clinical 
significance. Change on the depression subscale was not significant. 
4.2.2.3. Quality of Life 
Figure 4.2.8   Participant 2:  General quality of life at pre- and post-intervention  
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Change in general quality of life (see Figure 4.2.8) was clinically significant using 
the clinical distribution. Of the changes on the domains of quality of life (see Figure 
4.2.9) only physical QoL was significant using the reliable change index (RCI: 3.19). 
The change was also clinically significant as the change gave participant 2 a score 
which fell within the range expected in a non-clinical population at post-intervention. 
Figure 4.2.9  Participant 2: Quality of life domains at pre- and post-intervention 
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4.2.2.4. Awareness & Acceptance 
Figure 4.2.10   Participant 2:  Awareness and Acceptance at pre- and post-
intervention  
 
Changes in Awareness and Acceptance (see Figure 4.2.10) did not show reliable 
change (RCIs of 0.78 and 0.96, respectively). 
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4.2.3. Participant 3 
4.2.3.1. Symptoms 
Figure 4.2.11   Participant 3: Pre- and post-intervention scores on symptom 
measures  
 
Changes on symptom measures were not significant using the reliable change index 
and did not meet the cut-off for clinical significance.  
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4.2.3.2. Psychological distress 
Figure 4.2.12   Participant 3:  Pre- and post-intervention scores on HADS 
anxiety and depression scales  
 
Participant 3 showed no change on the anxiety subscale of the HADS. Change on the 
depression subscale (see Figure 4.2.12) was non-significant on the reliable change 
index (0.98).  
4.2.3.3. Quality of Life 
Figure 4.2.13   Participant 3:  General quality of life at pre- and post-
intervention  
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There was no change in general QoL score at post-intervention for participant 3 (see 
Figure 4.2.13). None of the changes in QoL domain (see Figure 4.2.14) were found 
to be significant using the reliable change index analyses.  
Figure 4.2.14  Participant 3: Quality of life domains at pre- and post-
intervention 
 
4.2.3.4. Awareness & Acceptance 
Figure 4.2.15   Participant 3: Awareness and Acceptance at pre- and post-
intervention  
 
Though changes in Awareness subscale of the PHLMS (see Figure 4.2.15) put 
participant 3‘s scores in the non-clinical range, the change the RCI (1.56) fell below 
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the cut-off for significance.  Changes in levels of Acceptance were non-significant 
using both reliable change and clinical significance calculations. 
4.2.4. Participant 4 
4.2.4.1. Symptoms 
Figure 4.2.16   Participant 4:  Pre- and post-intervention scores on symptom 
measures 
 
Reduction in symptom frequency (see Figure 4.2.16) was clinically significant for 
participant 4. Symptom severity did not change however, and change on the somatic 
subscale of the SCL-90-R was not significant using reliable change analyses. 
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4.2.4.2. Psychological distress 
Figure 4.2.17    Participant 4:  Pre- and post-intervention scores on HADS 
anxiety and depression scales  
 
Changes in anxiety and depression (see Figure 4.2.17) at post-intervention were not 
significant using the RCI (0.85 and 1.47, respectively). 
4.2.4.3. Quality of Life 
Figure 4.2.18   Participant 4: General quality of life at pre- and post-
intervention  
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Change in general QoL at post-intervention (see Figure 4.2.18) was not clinically 
significant and none of the QoL domains showed significant reliable change.  
Figure 4.2.19   Participant 4: Quality of life domains at pre- and post-
intervention 
 
4.2.4.4. Awareness & Acceptance 
Figure 4.2.20   Participant 4: Awareness and Acceptance at pre- and post-
intervention 
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The increase in Awareness shown by participant 4 at post-intervention (see Figure 
4.2.20 ) was significant using the reliable change index (RCI: 2.34) and this was 
clinically significant, putting the participant‘s score in the range of a non-clinical 
sample. Changes in Acceptance were not significant on the reliable change index 
(1.53). 
4.2.5. Participant 5 
4.2.5.1. Symptoms 
Figure 4.2.21   Participant 5: Pre- and post-intervention scores on symptom 
measures 
 
Reduction in symptom frequency (see Figure 4.2.21) was clinically significant for 
participant 5, though change in severity was not. Change on the somatic subscale of 
the SCL-90-R was significant on the reliable change index (RCI: 2.43). The change 
was clinically significant, placing participant 5‘s score within the range of a non-
clinical sample. 
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4.2.5.2. Psychological distress 
Figure 4.2.22   Participant 5: Pre- and post-intervention scores on HADS 
anxiety and depression scales  
 
Participant 5 showed no change in anxiety, and change on the depression scale of the 
HADS (see Figure 4.2.22) did not reach the reliable change index cut-off for 
significance. 
4.2.5.3. Quality of Life 
Figure 4.2.23  Participant 5: General quality of life at pre- and post-intervention  
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Improvement in general QoL (see Figure 4.2.23) was clinically significant, however 
none of the domains showed significant reliable change. 
 
4.2.5.4. Awareness & Acceptance 
Figure 4.2.24   Participant 5: Awareness and Acceptance at pre- and post-
intervention  
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Participant 5 showed a reduction on the Awareness subscale of the PHLMS (see 
Figure 4.2.24) which was significant on the reliable change index (RCI: -2.34), 
however this was in the direction of reduced rather than increased awareness. 
4.3. Participant feedback on the intervention 
Four of the participants who returned the post-intervention questionnaires completed 
the final section which asked for feedback on the self-help intervention. Comments 
from participants suggested that they found the booklet and CD intervention easy to 
follow. Feedback also suggested that the intervention‘s flexibility was helpful in that 
it could be done where and when it suited participants. One participant commented 
that they found the increase in awareness particularly positive.  
Recommendations to improve the booklet included a suggestion that the booklet 
could be made more appealing by using colour images. Another participant 
commented that face to face or group sessions could improve the intervention.  
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5. Additional Discussion 
Some of this study‘s outcomes were discussed in the journal article in Chapter 3. 
Discussion which was not included in this article can be found in the following 
sections. 
5.1. Outcomes of the study 
5.1.1. Relationship between mindfulness and outcomes 
As there was no active control to compare outcomes against, improvements observed 
could be due to participants being part of a research study. In an attempt to address 
this, correlations between change in mindfulness and change in outcome variables 
were carried out to assess if improved mindfulness was associated with 
improvements in outcome. Interestingly, the only significant relationship identified 
was a positive relationship between changes on the awareness subscale of the 
PHLMS mindfulness measures and changes in symptoms measured on the SCL-90-R 
somatic subscale. This suggests that increased awareness was related with worsening 
symptoms. As with more positive results, given the small sample and limited power, 
interpretations of these finding are tentative. One hypothesis could be, however, that 
increased awareness results in people with MUS noticing their symptoms more 
acutely. This might imply that participants carrying out the self-help MBSR did not 
have the guidance to control their awareness in the non-judgemental and accepting 
way that is the aim of mindfulness-based interventions.  
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The results identified in this study, though limited, suggest that levels of acceptance 
could be improved through self-help MBSR. No clear association was found, 
however, between the improvements in acceptance and the improvements in 
symptom frequency made by the completer sample. As a result these limited findings 
do not provide evidence to support Cardacciotto and colleagues‘ proposal that 
improvements in acceptance play an important role in reducing mood problems 
(Cardaciotto et al., 2008).  
Most studies of MBSR for people with MUS do not include a measure of 
mindfulness; of those that do, fewer still look at the relationship between changes in 
mindfulness and changes in outcome. One study evaluating MBSR for IBS which did 
include a mindfulness measure (the FFMQ), and carried out such correlations, did 
not find a relationship between improvements in mindfulness and improvements in 
anxiety at post-intervention, or at six month follow-up (Kearney et al., 2011b). They 
did identify a relationship, however, when changes were analysed across the three 
time points. This could mean that mindfulness measures are not sufficiently 
capturing mindfulness, or that there is another psychological process responsible for 
the change that is occurring, which is not encapsulated in mindfulness and its 
associated measures.   
5.1.2. Outcomes by participant 
Looking at the changes in outcomes observed in individual participants (see Chapter 
4.2) provides us with information about if changes were reliable and clinically 
significant for patients. These results showed that four of the five participants who 
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completed the intervention showed reliable and clinically significant change on one 
or more of the outcome measures. Reliable and clinically significant reduction in 
symptoms (as measured on the SCL-90-R somatic symptom subscale) and 
improvements in physical QoL were observed in two participants. Changes in 
anxiety, psychological QoL and Awareness met the criteria for both reliable and 
clinically significant change in one participant each.   
There were a number of cases where changes were either reliable, but their post-
intervention score did not fall below the cut-off for clinical significance, or their 
scores fell within the range typical of the ‗normal‘ population, but that the change did 
not meet the criteria for it to be considered reliable.  
The clinical significance calculations suggest that all participants who completed the 
intervention experienced clinically significant levels of symptom frequency at post-
intervention. While reliable change could not be calculated for this outcome, due to 
lack of information on scale reliability, it is interesting to note that symptoms were 
reduced to this level in all participants. This complements the analyses of statistical 
significance (see Chapter 3.3) which found symptom frequency to reduce 
significantly. 
Other than symptom frequency, the results do not show a clear pattern of change. 
Changes in anxiety and physical QoL were observed in two of the four participants 
who showed reliable and clinical change on one of the outcome measures but the 
other changes were only observed in one participant each. Again, this fits with the 
statistical analyses which showed that of the outcome measures only symptom 
frequency showed a statistically significant change at post-intervention.  
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These reliable and clinical change analyses help to identify where change has been 
reliable, and if participants have moved into a range typical of a non-clinical 
population. It does not, of course, tell us to what extent this has had a meaningful 
impact for an individual on their functioning and well-being. For example, a patient 
who has a relatively high anxiety score pre-intervention may show reliable change 
but not clinically significant change because there post-intervention score was not 
low enough. This person may, however, experience a greater benefit than the 
individual whose final score fell into the clinically significant range.   
The results show, however that it is possible that the MBSR intervention may impact 
on people with a range of different symptoms in a range on different ways. The 
individual results suggest that there is the potential for change in a range of different 
areas following the MBSR intervention including symptoms, anxiety and quality of 
life. Further investigation is needed to identify if the intervention is effective, in what 
cases, and in what areas change is observed. 
5.2. The roles of awareness and acceptance 
Lower levels of awareness have been identified in clinical samples when compared 
with non-clinical samples (Cardaciotto et al., 2008). The current study found, 
however, that participants‘ baseline levels of awareness were relatively high, and 
comparable with the non-clinical sample seen by Cardaccioto, raising the questions 
of if, and why, people with MUS have higher levels of awareness than other clinical 
samples. Theories of conscious awareness, including that by Gallagher (2005), 
propose that it plays little part in our daily life and that automatic bodily processes 
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remain largely outside our sphere of awareness. Gallagher goes on to suggest, 
however, that at times processes and sensations which would normally go unnoticed 
can be brought to the surface by changes in cognition or physiology, and that these 
can interfere with the normal functioning of what are usually unconscious processes. 
Similarly, the two stage model of medically unexplained symptoms proposed by Rief 
& Barsky (2005) posits that chronic stress and over-arousal generate bodily 
symptoms, and that these symptoms are then selected for conscious attention through 
a number of contributing factors including depression, health anxiety and uncertainty 
regarding symptom origins. They suggest that these factors lead to ‗faulty filtering‘ 
and an increase in the perception of symptoms. Though conclusions about the reason 
for the relatively high levels of baseline awareness in the participants cannot be 
drawn from this study, these models of MUS provide one way of understanding this 
finding. 
The high baseline levels of awareness identified in participants also highlights the 
different processes or factors involved in mindfulness. It has been proposed that the 
first component of MBSR involves the regulation of attention and awareness (Bishop 
et al., 2004). The results in the current study suggest, however, that high levels of 
awareness alone do not improve symptoms and distress in people with MUS. Instead, 
they support the idea that the second component of mindfulness, which involves a 
stance of openness, curiosity, and acceptance, is also necessary. So while awareness 
is associated with mindfulness (Cardaciotto et al., 2008) it is only one facet, and does 
not equate with mindfulness. In fact, as seen in the models outlined above, being 
‗aware‘ can maintain symptoms, while paying attention on purpose, in the present 
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moment and without judgement, can lead to increased levels of acceptance, and 
potentially the associated improvements in symptoms and psychological distress that 
have been identified previously (Cardaciotto et al., 2008). This differentiation 
between general awareness and conscious, open, non-judgemental awareness could 
explain the finding that increased awareness was associated with higher reported 
levels of symptoms (see Chapter 5.1.1), with increases in this general awareness 
(separate from acceptance or mindfulness) being related to increased symptom 
reporting. 
5.3. Changes to the original project 
The design and projected recruitment for the original study was led by prevalence 
figures for patients with MUS attending primary care, and the guidance of GPs who 
reported that they saw such patients regularly, and would be keen to have something 
to offer them. As a result, the study was designed as a randomised controlled trial, 
aiming to enrol 90 participants who would be randomly allocated to the intervention 
and ‗treatment-as-usual‘ conditions. Recruitment began in this way, however at a 
much slower rate than anticipated. During this time contact was maintained with the 
practices in person, by email and by phone, to try to ensure that project recruitment 
was kept in mind and to answer any questions or difficulties that arose in the 
practices. 
The project was expanded so that practices could search their databases for patients 
with relevant diagnostic labels, review them to identify that they met the diagnostic 
criteria, then send appropriate patients a participant information pack. Patients 
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identified by their GP as meeting the criteria were then sent the project information 
packs by the practice. Only one of the smaller practices took up this alternative 
method of recruitment, with other practices citing time and resource limitations for 
not doing so. Patients with fibromyalgia were also added to the inclusion criteria 
following feedback from GPs. In addition, two further GP practices were signed up 
to the study to aid recruitment. 
Despite these adjustments, it became clear that initial estimates regarding recruitment 
were not going to be met. As such, the design of the study was adapted to the within-
subjects design outlined in Study 1. While this would reduce the robustness of the 
findings, with any changes unable to be compared to a control group, it was decided 
that a smaller number of participants in a within-subjects study would be preferable 
to the same smaller number of participants being split between control and 
intervention groups, limiting further the potential to evaluate the intervention. 
Furthermore, the study was initially designed to include a three month follow-up 
however, due to the length of time that it took to recruit participants, it was not 
possible to carry out this follow-up. 
5.4. Potential reasons for recruitment difficulties 
Exploring some of the reasons behind the recruitment difficulties was important, 
initially as a means of adjusting the project, and later as a means of guiding future 
practice recruiting such participants. 
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5.4.1. Patient issues 
GPs were not asked to keep data regarding which, or how many, patients they 
introduced the project to as the investigator was aware, from experience and an 
initial GP focus group, that the time and effort required by GPs to carry out their role 
needed to be kept to a minimum. As a result, it is unclear how many potentially 
suitable patients were introduced to the project but were not interested, or took the 
pack but did not complete and return the forms to the project team. Feedback from 
GPs suggests that there were patients who were given a participant information pack 
but who did not complete and return the project paperwork to enrol in the study.  
While getting conclusive reasons for the low uptake is difficult there are a number of 
potential reasons which could help to explain the low uptake. Firstly, the introduction 
that GPs were asked to give patients about the project was kept very brief and was 
focused solely on introducing the idea of the project to patients, who would then 
have to go away and read about it in their own time. In addition, though GPs had 
been briefed about the intervention they did not have the intervention to give to 
patients as, for the purposes of the project, completed consent and baseline measures 
were needed before participants received this. As such, patients may have agreed to 
take a pack but did not go away and read the information, or they read the 
information but decided that they were no longer interested.  
Another possibility is that, depending on how long they have had their symptoms, 
some patients with MUS may not have been ready to consider managing their 
symptoms as their focus may still be on finding a cause and a remedy. Furthermore, 
patients who have had their symptoms for a long time might be very entrenched in 
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the biomedical model, and as result not be open to trying something more 
psychological. The psychological aspect of this intervention was not emphasised to 
participants as it had been identified that some patients with MUS can be put-off by 
the term ‗psychological‘ due to the mistaken belief that this means that their 
symptoms are perceived as being ‗all in the head‘ (Stone et al., 2002). As the lead 
researcher worked in psychological services, and return envelopes were addressed to 
the psychology department, potential participants could have been put off by this 
connection.  
5.4.2. GP issues 
Despite the possible reasons for patients not participating in the project, discussions 
with contacts in the medical practices during recruitment suggested that they were 
not giving out as many project information packs as had been anticipated. A number 
of different explanations for this were proposed by GPs, including: not seeing 
patients who met the inclusion criteria; seeing patients with MUS not included in the 
criteria; having difficulty remembering to offer involvement to potential participants, 
and not diagnosing patients with these labels. 
Other reasons for GPs not introducing the project were considered. One possibility 
was that GPs did not thinking that the MBSR intervention would be useful for 
potential participants, or that they thought the self-help aspect of the intervention 
would not be suitable for their patients.  
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5.5. Reflections on recruitment difficulties 
Recruitment was clearly a major challenge experienced when carrying out this study 
and these difficulties have limited the evaluation of the intervention and its ability to 
generate generalisable conclusions about its use in this population. As a result, 
considering what could have been done differently to avoid or better deal with these 
difficulties has proved to be an important aspect of the project.  
During the course of recruitment numerous changes were implemented in an attempt 
to deal with the recruitment difficulties, including: maintaining contact with GPs and 
practices, involving more practices in recruitment, broadening the inclusion criteria, 
adding an additional method of recruitment, and changing the design to a within-
subjects design. While these changes may have had some impact on the final number 
of patients recruited to the project they clearly were not sufficient to increase 
numbers to the planned level. On reflection there are a number of things which could 
have been done differently at different stages of the process which may have avoided 
the pit-falls experienced, and these considerations may be of use to researchers 
recruiting in this area, or using similar methods in the future. 
Firstly, despite good relationships with GPs and medical practices, and their initial 
enthusiasm for the project, recruitment through GPs was difficult and the anticipated 
numbers of patients who could be recruited did not materialise. The reasons for this 
are investigated in Study 2 and will not be repeated here, however difficulties were 
experienced across practices, and a number of reasons were identified which led to 
GPs struggling to recruit patients to this study. As a result, though the aim was to 
evaluate the intervention in way which was as close how the intervention would be 
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offered as possible, the difficulties faced when requiring GPs to recruit meant that 
any benefit gained through this ecological style of recruitment was lost by the low 
numbers recruited. Consequently, the study was unable to carry out an appropriately 
powered evaluation. For this reason, those who intend to recruit participants via GP 
practices would benefit from considering the issues that have been highlighted here.  
An alternative option to recruiting through GPs would have been to recruit people 
with MUS from relevant organisations, groups or internet forums. While there are 
drawbacks to this method of recruitment, including the non-clinical setting and 
potential participant self-selection bias, initial well-powered studies evaluating the 
intervention in these more ideal conditions could help guide more rigorous ecological 
studies in the future. 
For a number of reasons, including delays gaining ethical approval, the time 
available to carry out recruitment and intervention was limited. Though the initial 
timescales appeared appropriate, with scope for flexibility to deal with problems that 
arose, the project had sufficient leeway to deal with the ethics delays, however it did 
not allow for as much flexibility when the project recruitment then proved 
problematic. For this reason, starting time-limited projects as early as possible, and 
building in a greater time contingency than might expected can only help when 
carrying out such studies. Having said this, opening recruitment to non-NHS patients 
would not have had to go back through NHS ethical review, which is one of the 
reasons why changing the study can take time. If this had been carried out when 
initial problems with recruitment were identified then recruitment could have been 
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expanded to a separate group of participants, not recruited by their GP, in time to 
complete the intervention.  
In addition, if there was more flexibility with regards to the timescale of this project 
a small initial pilot study would have proven invaluable in terms of highlighting any 
recruitment problems or other issues with the design which could then be adjusted 
prior to the implementation of the more comprehensive study. 
Even if the design of the study and its recruitment were not changed drastically there 
are a number of other changes which could have been done, or could have been 
included in the original study design, which could have improved recruitment, or 
provided better feedback on why recruitment was not working as planned. Firstly, 
while it might have placed a greater burden on GPs, having a method of getting 
feedback from patients who were offered inclusion but did not participate would be 
very valuable, as understanding their reasons for not signing up for the project could 
have informed current and future study design and recruitment. Similarly, building in 
a system where feedback could be gained from those participants who started but did 
not complete the intervention would also help to understand who might benefit from 
this, and why.   
Another possible flaw of recruitment was that GPs did not have access to the 
intervention booklets and CDs. It was considered necessary to get the completed 
baseline measures prior to the patient being given the intervention booklet, however 
in hindsight giving GPs a sample intervention booklet may have increased their 
connection to , understanding of, and enthusiasm for the intervention which might 
have improved recruitment. 
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One final reflection is that having no face-to-face contact with a therapist who knows 
the intervention is likely to have reduced the likelihood of patients engaging with, 
and completing, the intervention. Though this was originally planned as a self-help 
intervention which could be given out by GPs, with no therapist input, it is possible 
that the intervention might prove more useful in a guided self-help model where 
there is limited contact with a therapist. This would not only allow greater 
opportunity to engage patients in the intervention, and help to manage any 
difficulties that arise, but also provides greater possibility of gathering qualitative 
patient feedback on the intervention.   
5.6. Limitations of the study 
Limitations relating to the study‘s small sample size and lack of control group were 
considered in the journal article discussion (Chapter 3.4) and will not be repeated 
here. Instead, this section discusses some of the study‘s additional shortcomings.  
Information about the education level or type of employment of the participants 
involved was not gathered. Given the size of this study, meaningful comparisons of 
these areas could not have been made. However, though more recent comparisons 
could not be identified, the Scottish Borders was ranked 30
th
 of 32 Scottish local 
authorities in terms of median gross weekly earnings in 2011 (Pike, 2012). While the 
development of the intervention booklet included an attempt to ensure that the 
content was understandable by people from the general population, and did not 
require high levels of education to understand, it is possible that the attrition level, or 
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outcomes found, could have been impacted upon by participant education level as 
this was not be explored. 
One of the drawbacks of evaluating a self-help intervention is that it is not possible to 
objectively say to what extent participants carried out the intervention. For example, 
in many MBSR studies, participants are usually considered to have completed the 
MBSR programme if they attend four out of the eight sessions (Schmidt et al., 2011; 
Sephton et al., 2007). So while participants who returned the post-intervention 
questionnaire reported the degree to which they carried out the intervention there was 
no independent measure which could be used to evaluate dose-response rates for the 
intervention.  
5.7. Implications for practice 
While the results of this study are not able to support the evidence-based use of a 
self-help MBSR intervention for patients with MUS, the findings may still have 
implications for practice.  
Limited change was observed in levels of awareness in those who completed the 
intervention, however improvements were made in their levels of acceptance. As 
self-help based MBSR interventions have received little investigation until now, this 
improvement in levels of acceptance provides some support for the idea that MBSR 
could be carried out in this way, by some patients. A small randomised control study 
of a self-help based acceptance and commitment therapy (ACT) -- a third-wave 
cognitive behaviour therapy which includes mindfulness strategies to increase 
psychological flexibility -- for people with chronic pain, was conducted recently 
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(Johnston et al., 2010). Though the small sample size (6 in the intervention; 8 in the 
control group) limited the generalisability of their results, they did find that anxiety, 
QoL and acceptance improved in the intervention group. ACT and MBSR are 
distinct therapies, however their third-wave focus on changing the function or 
process of psychological experiences rather than changing or modifying their 
content, and their use of mindfulness as a core component, mean that they share 
important similarities. This suggests that use of self-help interventions using 
mindfulness techniques can be acceptable and beneficial to those who experience 
physical symptoms such as pain. 
Participants in Johnston‘s study reported, however, that they found the mindfulness 
parts of the book to be one of the most difficult parts of the intervention. So while the 
results of this, and the current study, suggest that self-help interventions using third 
wave therapies might be useful for patients with physical symptoms, it is possible 
that mindfulness is difficult to master in a self-help context. Again, larger studies 
would be needed for self-help interventions of this kind to be properly evaluated. 
Such studies would benefit from exploring how far mindfulness can be learned in 
this way, and if there are certain patient characteristics which make it more or less 
likely for them to engage in and complete the intervention. 
Two-thirds of patients in the current study who completed baseline measures did not 
complete post-intervention measures, which suggests that they may not have 
completed the intervention. It is possible, therefore, that self-help MBSR may only 
be acceptable for, and beneficial to, a relatively small proportion of patients with 
MUS. Equally, further investigation may find the self-help intervention to have 
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relatively small effect on outcomes. Despite this, given the particularly low cost to 
implement the self-help intervention, the size of the MUS population, and the 
considerable cost to the NHS of managing these conditions, if benefits were 
identified it could potentially have a considerable impact across services as a whole.  
The argument for increasing access to psychological therapies in Scotland has been 
made for a number of years now (Scottish Executive, 2006). This has driven a move 
towards stepped or matched care models of psychological intervention where 
intensity of patient input is kept to the minimum needed, whilst still achieving good 
clinical outcomes (Scottish Executive, 2008). Having a similar model of care for 
patients with MUS, through the development and evaluation of self-help materials, in 
addition to group and one-to-one interventions, would appear to be beneficial not 
only for patients, but also financially for the NHS. Participants who completed 
follow-up questionnaires had lower levels of anxiety and depression at baseline than 
those who did not. This suggests that the intervention is more acceptable, and 
possibly more appropriate, for this population than for those with higher levels of 
anxiety and depression. While this theory requires more evidence to support it, it 
would fit within the matched care model, with self-help interventions being easily 
accessed by patients with less severe or complex problems, and who are not 
appropriate for, or willing to attend, individual or group interventions.  
Though it was not originally designed for use in this area it is possible that clinically, 
and perhaps from a research perspective, this intervention might be better provided to 
those who already have contact with mental health services. During the initial 
development of the intervention staff from a community mental health team 
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reviewed and commented on the booklet. The feedback was very positive, with staff 
reporting that they would like to be able to offer it to their patients. In this setting 
patients could be introduced to the intervention by a nurse, OT, psychologist or other 
team member who could provide motivation and guidance initially, something which 
is difficult for a GP to provide. Another option would be to follow the model of the 
ACT self-help intervention (Johnston et al., 2010) where weekly phone call support 
was included in the intervention. Though this would increase the necessary clinical 
input, and the resulting cost of the intervention, it is possible that including this type 
of support would keep patients engaged in the intervention and produce better 
outcomes as a result. 
5.8. Implications for research 
Firm conclusions about how far self-help MBSR can improve mindfulness in 
participants with MUS, and to what extent these improvements are associated with 
changes in symptoms, QoL and psychological distress, could not be drawn from this 
study due to the low sample size. As so many studies of MBSR for MUS lack a 
measure of mindfulness the process of change that is identified in these studies 
cannot be fully explored or understood. Having a better understanding of the 
psychological mechanisms responsible for change in MBSR would aid the 
development and refinement of such interventions, and could have implications for 
how they are provided, and guide who they are offered to. Including mindfulness 
measures in studies involving mindfulness-based interventions could not only 
confirm that mindfulness improves as a result of the interventions, and identify if 
changes in outcomes are associated with these improvements in mindfulness, they 
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could also help to provide a better understanding of the mechanisms involved in 
therapeutic change in mindfulness and MBSR. 
Numerous attempts have been made to develop and evaluate interventions for 
patients with MUS in primary care but an effective treatment model has yet to be 
established. For example, studies of a re-attribution intervention delivered by trained 
GPs (Larische et al., 2004), and CBT provided by GPs in primary care have been 
found to be no more efficacious than treatment as usual (Arnold et al., 2009; 
Sumathipala et al., 2008). Self-help CBT for IBS has been found to have some 
benefit in reducing reported symptoms in patients with MUS, but had no impact on 
anxiety or depression (Moss-Morris et al., 2010). Encouragingly, however, in 
addition to the study by Johnston et al. (2010), a recent study has found 
improvements in QoL and IBS behaviours following an ACT-based guided self-help 
intervention for IBS (Ferreira, 2011).  
The results of the current study do not show that this self-help MBSR intervention 
can improve on the outcomes observed in these interventions, however the treatment 
of MUS in primary care requires further investigation and the results found show 
sufficient improvement in outcomes to focus further research in this area. 
In addition to exploring the efficacy of self-help MBSR in improving patient 
outcomes, as patients with MUS have high health service utilisation costs (Barsky et 
al., 2001), and the number of somatic symptoms that patients have correlates with 
these costs (Tylee & Gandhi, 2005), an economic costs-benefits analysis of the 
intervention would be an important area for future research to consider. This could 
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be carried out by comparing participants‘ attendance at their GP, or other medical 
contact, over the six months prior to, and the six months following, the intervention. 
This would provide a way of evaluating direct economic benefit of the intervention, 
though it would not take into account broader economic issues such as the ability to 
work or number of sick days, for example. 
5.9. Conclusions 
The original study was designed to be a randomised controlled trial with a 
substantially greater sample size than the current study, and a follow-up assessment. 
This was adapted in a number of ways due to difficulties with recruitment, resulting 
in the current study. Potential reasons for the limited recruitment were considered 
from both patient and GP perspective, and feedback from GPs suggested that they 
were experiencing a number of issues which meant that recruitment was lower than it 
could have been.  
No expected relationship was identified between increased mindfulness factors and 
improvements in psychological distress, QoL or symptoms. The only relationship 
identified was between increased awareness and increased symptoms, implying that 
the self-help intervention may not have been sufficient to develop the mindful 
awareness necessary to have a positive effect on symptoms. The results of this study 
emphasise the different aspects or factors involved in mindfulness, highlighting the 
difference between general awareness and the present moment, curious and non-
judgemental nature of mindful awareness which MBSR attempts to foster.  
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The current research cannot support the evidence-based use of the self-help MBSR 
intervention for patients with MUS due to its limited findings. However, the findings 
suggest that further study would be warranted to ascertain if self-help interventions 
such as this can increase mindfulness in this population, and if this results in 
improvements in psychological distress, QoL or symptoms. The potential benefits to 
patient wellbeing, and financially to the NHS and wider economy, make this an area 
worth pursuing. A suitably powered sample size would be required for the 
intervention to be appropriately evaluated, however. To do this effectively, a greater 
understanding of the recruitment difficulties faced in this study could help to adjust, 
or provide alternative, recruitment strategies and similar problems could be avoided. 
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Abstract 
Background: Difficulty recruiting patients to Study 1 through routine GP 
appointments led to limitations in the evaluation of the intervention. Limited research 
exists exploring this area, but it suggests that brief focussed questionnaires can be 
used to explore these difficulties with GPs. The aim of this study was to understand 
some of the difficulties experienced with a view to informing future research and 
intervention implementation. 
Method: Practices were contacted and asked if they would prefer paper or web-
based questionnaires. Thirty-five GPs involved in recruitment to Study 2 were sent 
the questionnaire which asked them to rate how true they found ten statements to be 
on a five-point Likert scale. They were also asked to estimate the number of patients 
they had introduced the project to. 
Results: Twenty-two (63%) GPs completed and returned the questionnaire. Three 
statements were scored higher than the others. The first two were related to finding it 
hard to prioritise amongst competing demands and forgetting to offer patients 
participation as they were very busy. The third was that GPs saw patients with 
medically unexplained symptoms but they did not meet the inclusion criteria.  
Conclusions: Recruitment appears to have been impacted on by GP finding it 
difficult to prioritise, being busy and forgetting, and seeing patients who had MUS 
but who did not fit the inclusion criteria. As a result, alternative ways of evaluating 
this type of intervention, including recruiting participants through relevant 
organisations, may need to be considered to evaluate their efficacy.  
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6. Study 2 Introduction 
Despite changes to the initial project (see Discussion, Chapter 5.3), involving more 
practices in recruitment; broadening inclusion criteria to include fibromyalgia; 
offering a different way of recruiting participants; changing the study to a within-
subjects design as described in the Methods section (Chapter 0); and on-going 
contact with the practices, recruitment to the pilot project remained considerably 
lower than anticipated. As a result, a better understanding of the difficulties 
recruiting participants to Study 1 was sought, which led to this additional study being 
carried out. Despite initial positive responses from GPs about involvement in the 
study, once recruitment was underway they reported difficulties. The rationale 
behind this study was, therefore, to try to understand these recruitment difficulties 
through a questionnaire to GPs involved in Study 1. Such findings could have 
implications for the design and implementation of future research in addition to 
helping to inform how the intervention might be best used in practice. 
Prior to beginning Study 2, GPs from a number of practices involved in the 
recruitment of participants for Study 1 were canvassed on possible options for the 
study. Options were: a) for a small number of GPs to be involved in interviews about 
their experience of recruitment and their thoughts around medically unexplained 
symptoms more generally; or b) for all GPs involved in Study 1 to be given a short 
questionnaire around potential recruitment difficulties. Their response was 
unanimous, reporting a preference for questionnaires, with a prediction that there 
would be a higher chance of a reasonable number of short questionnaires being 
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completed than there would be of an appropriate number of GPs committing to take 
part in interviews (due to time commitments and other demands being placed on 
them).   
6.1. Literature on difficulties recruiting patients 
There is a considerable literature exploring the difficulties carrying out collaborative 
clinical research within healthcare systems such as the NHS. Most of this research 
has focused on difficulties engaging health professionals in research, with less 
attention given to the barriers that those health professional who have agreed to take 
part have faced when recruiting patients. Despite this, difficulties arising when GPs 
have agreed to introduce research to patients during consultations are not uncommon 
(Fairhurst & Dowrick, 1996; Hetherton et al., 2004; Mason et al., 2007). Hetherton 
and colleagues‘ study (2004), comparing computerised CBT, psychologist-lead CBT, 
and treatment as usual by GPs, relied on GPs introducing the study to potential 
patients. They only recruited five participants within a three month period 
(prompting modification of the study design) and 17 within a year. The researchers 
then gave a questionnaire to GPs involved in recruitment to identify potential barriers 
to recruitment. This drew on a questionnaire developed by Fairhurst and Dowrick 
(1996) when their RCT had to be abandoned due to GPs recruiting insufficient 
numbers of patients. Some GPs reported that the questionnaire given by Hetherton 
and colleagues to identify barriers to recruitment was too long and they asked to be 
interviewed to feed back their thoughts. 
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The questionnaires and interviews by Hetherton et al. found that GPs felt faced with 
a dilemma between the care of their patients and research interests. For example, GPs 
felt uncomfortable about patients being randomised to conditions and this often 
resulted in the research not being introduced to patients. GPs were also concerned 
that the intervention would not meet the needs of the patients, and felt uncomfortable 
about raising the research due to its potential to impact on the consultation. In 
addition, Hetherton et al. identified that GPs found it difficult to prioritise the study 
in the face of competing demands.  
A qualitative study, also exploring the barriers experienced in this type of 
recruitment, was carried out by Mason and colleagues (2007). Their analysis of 
interviews with GPs found that a desire to protect the doctor–patient relationship, a 
perceived lack of skill and confidence in introducing research to patients, and priority 
being given to clinical and administrative matters over research participation, were 
the main themes that arose.  
6.2. Maximising questionnaire response rates 
Getting adequate response rates to questionnaires can be difficult, particularly when 
the number of individuals who can be included in the study is limited. Research in 
this area suggests a number of things that can be done to maximise responses. When 
using online questionnaires a short, simple format (Crawford et al., 2001), an 
introductory letter or email including details of the estimated time to complete 
(Porter, 2004), and emphasising anonymity (Michaelidou & Dibb, 2006), have all 
been found to increase response rates.  
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A single reminder email has been found to double response rates (Crawford et al., 
2001), while another study found that each additional contact, up to a maximum of 
four (pre-questionnaire contact, questionnaire, and two reminders), continued to 
yield increased response rates (Schaefer & Dillman, 1998). Acknowledging that GPs 
get a lot of questionnaires, and as such response rates are not always very high, 
Barclay et al. (2001) carried out a study into how to maximise GPs‘ response rates to 
postal questionnaires. They also found that response rates rose with each of three 
contacts (initial contact: 36.9%; first reminder: 14.9%; and second reminder: 11.4%) 
but that responses flattened out at this point, with another prompt yielding only 4%. 
Including the initial request and three additional reminders, Barclay et al. achieved a 
final response rate of 67.7%.  
Web-based questionnaires have become increasingly popular due to their ability to 
collect a large amount of data relatively quickly, and the fact that data is 
automatically collated, eliminating the need for researchers to input it individually. A 
study by Kaplowitz et al. (2004) found that, in a population that knows how to use 
the internet and has easy access to it, a web-based survey achieves similar response 
rates to those delivered by mail. In addition, web-based surveys can include a 
message to inform users when an item has not been completed which can reduce, or 
eliminate, missing data (Michaelidou & Dibb, 2006). It has been suggested that using 
a mixed mode design, where both paper and web-based options are offered might 
increase respondents' motivation to complete the questionnaire (Dillman, 2007; 
Schaefer & Dillman, 1998). 
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6.3. Aim of the study 
Study 2 explores the reasons for the recruitment difficulties experienced in Study 1 
with a view to aiding the design and implementation of similar research in the future. 
In addition, the results of this study could provide guidance on how the intervention 
evaluated in Study 1 might be better implemented in practice.  
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7. Study 2 Methods 
7.1. Ethical considerations 
The only ethical concern identified for this study was around GP confidentiality. As 
a result, questionnaires were anonymous and GPs were informed of this on the 
questionnaire. The South of Scotland Research Ethics Committee 3 approved this 
amendment to the initial project (Appendix 8), as did NHS Research and 
Development (Appendix 9).  
7.2. Participants 
Initially, contact was made with the relevant person in each of the eight medical 
practices involved in Study 1 to inform them of this extension to the project, and to 
agree the method of questionnaire distribution. All practices involved in Study 1were 
asked to participate in the current study. Seven out of the eight practices involved 
agreed for the questionnaires to be distributed to their GPs. On discussion with the 
eighth practice (with ten GPs) it was agreed that their GPs would not to be sent the 
questionnaire due to difficult circumstances that they were dealing with at the time. 
All GPs in the seven participating practices were sent the questionnaire. These 35 
GPs were considered potential participants. 
7.3. Measures 
The lead researcher developed a questionnaire to be completed by GPs in 
participating practices. The content of the questionnaire was developed based on 
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informal feedback from GPs, information from previous research, and guidance from 
a GP who had also experienced difficulties recruiting patients through GPs. As a 
result of feedback from GPs, and evidence from previous studies of this kind, the 
questionnaire was kept as short as possible. The questionnaire consisted of: 
 A question asking respondents to confirm that they were a GP. 
 A question asking if they knew about the project. 
 A question asking them to estimate the number of people they discussed the 
Study 1 project with. 
 Ten statements to be rated on a 5-point Likert scale from ―5 - Always true‖ 
to ―1-Never true‖. 
 One free text box for respondents to identify any other issues that they 
thought might be responsible for the difficulty in recruiting participants. 
A paper version of the questionnaire was produced (see Appendix 11) in addition to 
a web-based version which was put on www.surveymonkey.com. Both versions 
included an introduction, reminding the GPs of the project that was being referred to, 
and explaining why they were being asked to complete it. It also informed them that 
the information gathered was anonymous, and it gave an estimated completion time. 
The web-based questionnaire automatically prompted GPs to complete any required 
questions that were missed. All questions were mandatory except the last question 
which asked them to identify any additional reasons for the difficulties recruiting. 
The web-based questionnaire kept a record of the number of questionnaires that were 
started, and the number that were completed. 
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7.4. Procedures 
Contact was made with each of the medical practices involved to introduce this 
extension to the project and to discuss whether the web-based or paper versions, or a 
combination, would be preferable to GPs in their practice. Most practices favoured 
the web-based questionnaire, with one practice using a mixture of paper and online 
versions. In addition to the initial request to complete the questionnaire two 
additional prompts were sent to GPs asking them to complete the questionnaire if 
they had not already done so.  
Data from completed web-based questionnaires were automatically collated. Data 
from paper questionnaires were transferred to the web-based survey.  
7.5. Analysis 
Descriptive statistics were used to analyse the results of this study due to its design. 
Barclay and colleagues‘ study of GPs had a response rate of 63% with two reminders 
in addition to the initial contact (Barclay et al., 2001). Due to previous contact with 
the medical practices, and their involvement in the study, a relatively high response 
rate was anticipated. However taking into account sick leave, annual leave, training, 
or GPs being out of the office for other reasons, a response rate similar to that found 
by Barclay et al. was expected. 
Information was gathered about the number of GPs who were unaware of the project. 
Means and standard deviations were calculated for each of the statements, with a 
possible range from one to five. A mean score of one suggests that all GPs felt a 
statement was ‗never true‘, and a mean score of five indicating all GPs felt the 
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statement was ‗always true‘. The percentage and number of GPs who gave each 
response was also calculated.  
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8. Study 2 Results 
Twenty-two (63%) of a potential 35 questionnaires were completed and returned. All 
19 surveys that were started online were completed. Of the 22 completed forms, all 
respondents confirmed that they were a GP and 21 (95.4%) reported that they were 
aware of the research project. The mean number of patients that individual GPs 
estimated they had introduced the project to was 2.27 (SD: 2.45), with a median of 1, 
a mode of 1, and a range of 0 to10.  
Mean scores, and the number and percentage of GPs who give each score for each of 
the ten statements can be seen in Table 8.1.  
Three statements, 8, 7 and 3, showed the highest mean scores, with means above 3 
(‗occasionally true‘). Statement 8, suggesting that it was difficult to prioritise the 
study in the face of competing demands, was scored highest, with a mean score of 
3.73 (SD: 1.4), between ‗occasionally true‘ and ‗usually true‘. Over two-thirds of 
GPs rated this statement as either ‗almost always‘ or ‗usually true‘. 
Statement number 7, which proposed that GPs were very busy and forgot to offer 
potential patients inclusion in the project, was the next highest scoring statement. 
The mean score for this statement was 3.50 (SD: 1.10), between ‗occasionally true‘ 
and ‗usually true‘. Almost a quarter of GPs reported that this statement was always 
true.  
   




 Table 8.1  Percentage (and number) of GPs giving each response (modal rating in bold) and mean score
Statement 
Almost 
always true - 5 
Usually 
true - 4 
Occasionally 
true - 3 
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Statement 3, suggesting that GPs saw patients with MUS but they did not meet 
inclusion criteria, was also a rated relatively highly with a mean score of 3.36 (SD: 
1.22), between ‗occasionally true‘ and ‗usually true‘. Nearly half of GPs rated 
statement 3 as ‗usually‘ or ‗almost always‘ true, with a further 41% reporting it to be 
‗occasionally true‘.  
Other statements showed more variation across GPs which resulted in lower mean 
scores. For example, GPs were split in their reported use of the diagnostic labels used 
in the inclusion criteria: statement 2 received a mean score of 2.59 (SD: 1.50), and 
though the majority of GPs stated that it was ‗usually not‘ or ‗almost never‘ true, 
over a third rated it as ‗usually‘ or ‗almost always‘ true. Similarly, while the majority 
of GPs (59%) rated it as ‗usually not‘ or ‗almost never‘ true, over 35% said that they 
‗occasionally‘ or ‗usually‘ did not feel that taking part in the research project was 
right for the patients that they saw.  
Despite relatively low mean scores, statements 5 and 6, relating to not wanting to 
make extra demands, and not thinking that self-help would be useful for patients, 
were most commonly rated ‗occasionally true‘ by GPs. Furthermore, while the 
majority of GPs stated that it was usually not, or never true that they thought 
mindfulness would not be beneficial to the patients they saw, almost a third reported 
it to be ‗occasionally‘ or ‗usually‘ true. 
Seven GPs provided comments about reasons for the difficulties experienced 
recruiting participants. No additional explanations were identified, however two 
patterns which support the quantitative data emerged from these comments. Some 
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comments emphasised the difficulties faced remembering to introduce the project 
when they were busy and faced other demands. Examples of this were:  
 In a busy surgery with 10 minute appointments just rarely had time to 
discuss. 
As GPs there's a lot to remember about different services/criteria etc 
and it's difficult to keep it all in your head! 
A comment about the inclusion criteria was also made. 
Many of the MUS patients I have don’t fit the diagnostic categories. It 
would have been helpful if these patients could have be included.  
This suggestion, that including patients with other medically unexplained symptoms 
might have been beneficial, also supports the quantitative findings.  
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9. Study 2 Discussion 
9.1. Outcomes of study 2 
All GPs who began the online questionnaire completed it, suggesting that the length 
and content of the questionnaire itself was acceptable to those who looked at it. 
Thirty-seven per cent of GPs did not complete the questionnaire, however, despite a 
total of three requests or reminders. This is consistent with one of the key results 
identified from the completed questionnaire: that GPs are very busy and find it 
difficult to remember, or to prioritise, involvement in research. The response rate is, 
however, comparable with previous research which also achieved a 63% response 
rate from an initial request and two reminders (Barclay et al., 2001).  
Three areas were identified as having the greatest impact on recruitment to Study 1. 
9.1.1. Area 1: Inclusion criteria too limited 
While GPs did see patients with MUS, those that they saw did not always meet the 
inclusion criteria for the project. During initial discussions with GPs about the 
development and evaluation of the intervention in Study 1 they suggested that 
specific categories -- such as irritable bowel, chronic fatigue and tension headaches -- 
be used in the inclusion criteria. They reported that they saw these MUS most 
commonly, and that such criteria would be easier to apply than a broad heading of 
―medically unexplained symptoms‖, which they thought was too loose.  
Despite attempts to make recruitment to the project relatively inclusive, by recruiting 
patients with a range of MUS, rather than one specific diagnosis, many GPs appear 
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to have seen patients with MUS, but who were ineligible for the study. There are a 
wide range of diagnoses that are applied to MUS but many patients are not given a 
diagnosis. Nimnuan et al. (2001) found that no clear diagnosis can be given in 20-
30% of primary care appointments, supporting the finding that a proportion of 
patients with MUS who are seen by GPs would not have met inclusion criteria for 
Study 1 as they would not have been given any of the labels in the inclusion criteria. 
There are number of reasons for this including lack of clarity about the aetiology of 
the symptoms, lack of treatment options, the presentation of symptoms not mapping 
onto any one diagnostic category, or understandable reservations on behalf of GPs 
about the utility of these diagnoses. 
9.1.2. Area 2: GPs were busy and forget 
The second area which explains some of the difficulty recruiting participants was 
that GPs were busy and forgot to offer potential participants inclusion in the project. 
Almost a quarter of GPs stated that this was almost always true of them, and the 
same proportion reporting it to usually be true. As a result, almost half of potential 
participants may have been missed as a result of this. So, despite GPs knowing about 
the project and being positive about involvement in it prior to implementation, the 
reality of a busy surgery and short consultation times appear to have been relatively 
widespread, resulting in not all potential participants being included. This finding 
supports previous research where time pressures and forgetfulness were found to be 
major factors in recruitment difficulties in primary care (Murphy et al., 1992; Peto et 
al., 1993). 
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9.1.3. Area 3: Difficulty prioritising the study 
GPs found it difficult to prioritise recruitment to Study 1 given the other demands 
upon them, and this appears to have had a resulting impact upon recruitment rates. 
This ties-in closely with the second area, where GPs reported being very busy, and is 
consistent with conclusions drawn in previous research which identified that other 
things took priority ahead of recruiting for research in a busy practice (Hetherton et 
al., 2004; Mason et al., 2007). Anecdotal evidence from a GP, that GPs and medical 
practices were under pressure to meet targets (unrelated to MUS) during the 
recruitment period, and that as a result the study would not have been a high priority, 
also supports this finding.  
9.1.4. Additional reasons for low recruitment 
These three areas seem to have the most consistent impact on recruitment to Study 1, 
however the results suggest that other factors might also have had an impact, albeit 
less consistent or strong. One example of this is that GPs were split with regards to 
whether they used the diagnostic labels in the criteria, with a substantial minority 
(over 36%) indicating that they did not usually use them. This is consistent with a 
previous study which found that 23% of GPs did not diagnose chronic fatigue 
syndrome (Bazelmans et al., 1999). It seems reasonable to suppose that the third of 
GPs who said they do not usually use the diagnostic labels would have been less 
likely to recruit potential patients as a result. 
In addition, though not reported as consistently as the three areas outlined above, a 
considerable proportion of GPs: occasionally did not want to make demands on 
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patients; thought that the research was not appropriate for some patients; and thought 
that introducing the research would impact on the consultation. These findings 
suggest that when faced with a patient who meets the inclusion criteria GPs do not 
automatically introduce the research, and that many factors influence the decision of 
whether to do this. Akin to the conclusions drawn by Hetherton et al. (2004), this 
implies that clinical judgement is often involved when GPs are asked to recruit their 
patients to research, resulting in those who meet the criteria not always being offered 
inclusion in the study. 
9.2. Numbers introduced to Study 1 
An awareness of the time restraints already placed on GPs led to efforts to ensure 
that the level of input required by them to introduce Study 1 to patients was kept to a 
minimum. As such, GPs were not asked to keep a record of the patients who they 
gave project information packs to. This meant that there was no way of identifying 
how many patients were offered the packs, or what proportion of the packs given out 
were completed and returned. The estimation by GPs of how many patients they had 
introduced the project to provides a rough guide to possible numbers, however.  
GPs who completed the questionnaire reported introducing the project to 2.27 
patients, on average, though most GPs reported introducing the project to one, or no, 
patients. Based on reports by the GPs who completed the questionnaire, the project 
was introduced to at least 50 participants. If it was assumed that the all GPs involved 
in Study 1 would introduce the same number as those who completed the 
questionnaire for Study 2, then a total of around 102 would be expected. It seems 
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reasonable to assume, however, that GPs who did not respond to the questionnaire in 
the current study were likely to have been less involved in promoting Study 1. In 
addition, the practice that did not participate in Study 2 had been involved in the 
project later than other practices, and had experienced difficulties within the practice 
following implementation, making it likely that recruitment there was very low. For 
these reasons, while other patients may have been offered involvement in the project, 
it is likely that the total number of patients with whom participation was discussed 
was closer to 50 than the 102 noted above. 
9.3. Reasons for patient non-participation 
Even if one assumes that only 50 patients were introduced to the study, over two-
thirds of these patients did not complete and return baseline measures. Naturally, we 
do not know why this is, though possible reasons include that on further discussion it 
became apparent that the patient was not eligible for the study; that the patient was 
not interested; or that they forgot to complete or return the measures. As return 
envelopes were addressed to Psychological Services another factor could be that 
continuing stigma and misperceptions about psychological services (Aromaa et al., 
2011) might have prevented patients from engaging in the project. 
Another possible explanation is that some patients that repeatedly attend their GP 
with MUS may be focused on finding a cause or a cure, or checking that nothing else 
has been missed. For this population, looking at symptom management may feel like 
giving up. This could be tied in with the fact that, though GPs largely knew about the 
project and its rationale, they did not have the intervention to give or show to patients 
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in the consultation. It is possible that as a result of this that they lacked sufficient 
knowledge, enthusiasm or confidence to engage patients in the project.  
High levels of depression and low mood have been identified in patients with 
medically unexplained symptoms (Aromaa et al., 2011; Bleichhardt et al., 2004; 
Escobar et al., 1998) and the low motivation and self-efficacy often experienced by 
such conditions may make it hard to opt in to, and then complete, a self-help 
intervention without more active guidance. Study 1 found that none of the 
participants who scored above the clinical cut-off for moderate depression at baseline 
completed follow-up measures. In addition to influencing completion of the 
intervention it is likely that higher levels of depression might also influence initial 
participation in such studies. 
9.4. Implications for future research 
The MBSR self-help intervention was initially developed out of a perceived need 
within primary care, identified both by GPs and patients with MUS. Study 1 tried to 
evaluate the MBSR intervention in an ecologically valid way, however the 
difficulties experienced recruiting participants like this limited the conclusions that 
could be drawn. Findings from this study suggest that the time and role demands 
placed on GPs make it very difficult for them to remember and to prioritise the 
recruitment of patients to research, even when their role in the study is kept to a 
minimum. In addition, it appears that GPs can be caught between their roles as a 
clinician and as a recruiter to research, and that their clinical judgement can play an 
important role in whether or not patients are recruited to research studies.  
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One possible way to avoid these issues of GPs‘ limited time and decision making 
impacting on recruitment in future research would be to run detailed searches of 
practice databases to identify potential participants, and contact them directly rather 
than GPs trying to remember during routine consultations. However, a limitation 
with this alternative method, as evidenced in this study, is that around a third of GPs 
do not regularly use the diagnostic labels used in the inclusion criteria, and even 
those that do use these terms might not code them as such. As a result patients with 
diagnoses used by the current study (such as fibromyalgia) would be difficult to 
identify through this type of search. 
An alternative option would be to pilot the intervention in a different way, initially, 
in order to evaluate its efficacy under more optimal circumstances prior to evaluating 
its effectiveness in primary care. This could be done by enrolling participants 
through support groups or related organisations. Though this would not provide 
results that could be generalised directly to clinical practice, greater information 
about any potential benefits could better inform more ecological studies in the future. 
Alternatively, the intervention could be evaluated within a guided self-help 
framework where participants would be introduced to the intervention by a 
practitioner who could provide on-going engagement, motivation and guidance – 
something that GPs are not in a position to offer. The direct patient contact involved 
in such a guided self-help model would provide the opportunity for more direct and 
detailed feedback from patients, which could be used to adapt and refine the 
intervention.   
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In addition, though guidance was sought from patients with MUS during the 
development of the self-help intervention, the extent of this was limited and more in-
depth investigation into what patients with MUS want, and how they view symptom 
management, would benefit this area of clinical research greatly. A qualitative study 
exploring these areas could provide a clearer basis for developing and evaluating 
this, and other, interventions in the future. Furthermore, studies recruiting 
participants in a similar way to Study 1 would benefit from asking patients who were 
introduced to the project, but did not participate, why this was. This could help in the 
development and modification of interventions which are not only effective, but also 
acceptable to patients with MUS.  
9.5. Implications for practice 
The difficulties faced by GPs in recruiting participants to Study 1 raised questions 
about whether GPs would give patients the intervention in practice, if they had it to 
offer patients outside the constraints of a research project, or if they did not see the 
benefits of the intervention for the population. The findings of this study suggest that 
the recruitment difficulties were not due to GPs being opposed to the intervention, 
but instead were largely to do with having limited time, and struggling to prioritise or 
remember to introduce the project. While having the ability to look at and show 
patients the booklet and CD might make GPs more likely to offer the intervention, it 
could also be beneficial to provide information and reminders to GPs about such 
interventions when they are introduced into practice. 
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9.6. Limitations of the study 
The questionnaire was designed to be short enough for GPs to be likely to complete 
it. While this seemed successful, with all GPs who started the online questionnaire 
completing it, it did mean that the number of questions was limited and more detailed 
reasons for the difficulties could not be established. For example, the findings of the 
current study suggest that recruitment is impacted on by other demands on GPs, but 
we cannot unpick what types of demands these were. Additionally, though some 
statements were rated more highly than others, a definite causal relationship between 
these findings and difficulties recruiting cannot be made.  
It is also important to keep in mind that GPs were providing reasons after the event 
and that there is the potential for bias in terms of memory, desirability of response 
and in those who opted to respond. GPs who did not engage with Study 1 are likely 
to be under-represented amongst those who completed the Study 2 questionnaire, and 
the reasons for their non-participation in Study 1may differ from those given by the 
current respondents.  
The study also focuses solely on the difficulties identified from GPs‘ perspectives. 
While potential reasons for limited uptake by patients were considered there was no 
direct input from patients in these considerations.  
9.7. Conclusions 
This study suggests that there were three main issues which played a relatively 
consistent role, across GPs, in hindering the recruitment of participants to Study 1. 
These included being busy and forgetting, finding it difficult to prioritise the 
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research, and seeing patients who had MUS but who did not fit the inclusion criteria. 
In addition, there was evidence that GPs might not have introduced the study to 
patients as their role as a clinician took priority over their role in the research. 
Recruiting participants through GPs in this way is, therefore, not ideal. As a result, 
alternative methods of recruitment for this type of study, through support groups or 
other relevant organisations for example, should be considered. This would mean 
that the efficacy of interventions, such as the self-help MBSR intervention outlined 
in Study1, could be evaluated prior to seeking to determine effectiveness.   
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11. Appendices 
Appendix 1.  Systematic review excluded studies & quality criteria scoring 
guidelines 
Appendix 1a. Table of studies excluded at second screening and 
reason for exclusion 
Study Reason for exclusion 
Asare et al. (2011)  Journal letter 
Astin et al. (2003)  MBSR not sole intervention (also Qigong 
movement therapy) 
Ernst et al. (2007)  No English version available 
Fjorback et al. (2011 Published conference abstract 
Gaylord et al.  (2011a)  Published conference abstract 
Kearney et al.  (2010a)  Published conference abstract 
Kearney et al.  (2010b)  Published conference abstract 
Kearney et al.  (2011)  Published conference abstract 
Pauzano-Slam (2005)  Thesis - could not be sourced and author 
could not be reached 
Surawy et al. (2005)  MBSR not sole intervention (combined 
with MBCT) 
Weissbecker et al. (2002)  Not an outcome study 
Zernicke et al.  (2011) Published conference abstract 
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i. Eligibility criteria are specified 
Well-covered (2) Inclusion criteria clearly detailed  
Adequately addressed (1) Inclusion criteria are not outlined clearly, though they can be 
ascertained from the details given. 
Poorly  addressed (0) Some information is given about eligibility for the trial, 
though it could not be confidently replicated. 
Not  addressed (0)  
Not applicable (0)  
 
ii. Patients are recruited in a clinical setting 
Well-covered (2) It is clear that patients have been recruited in a clinical 
setting and all (or random sample of) eligible potential 
participants were invited. 
Adequately addressed (1) Patients recruited in a clinical setting but potential bias in 
those approached that wasn‘t part of inclusion/exclusion 
criteria. 
Poorly addressed (0) Patients recruited in a clinical setting but clear bias in those 
approached that was not part of inclusion/exclusion criteria. 
Not addressed (0) Not recruited in a clinical setting 
Not applicable (0)  
 
iii. A control group is used 
Well-covered (2) A suitable control group is carried out alongside the 
experimental intervention group. This could be a TAU, 
waiting list or an active control group.  
Adequately addressed (1) An alternative intervention group is included but no control 
group. 
Poorly addressed (0)  
Not addressed (0)  











Appendix 1b. Quality criteria scoring guidelines 
 
   




iv. At least 1 of the therapists was experienced or trained in teaching 
mindfulness 
Well-covered (2) Evidence provided to show that at least one of the trainers 
was experienced or trained in teaching mindfulness (yrs 
experience etc) 
Adequately addressed (1) It is stated that one of the therapists is experienced or trained 
in mindfulness but no evidence is given to support this. 
Poorly addressed (0) Some information about the therapist‘s experience given but 
does not suggest ‗experienced‘.  
Not addressed (0) No description of the therapist‘s experience is given. 
Not applicable (0)  
 
v. Measures of psychological distress are robust 
Well-covered (2) Outcome measures robust for this population (valid, reliable 
- HADS, etc.) 
Adequately addressed (1) Outcome measures acceptable validity/psychometrics, or 
good robustness but not the most valid for this population. 
(GSI of SCL-R-90/BDI etc) 
Poorly addressed (0) Outcome measures poorly described and less robust. 
Not addressed (0)  
Not applicable (0)  
 
vi. Similar levels of psychological distress at baseline 
Well-covered (2) Clear details of differences in psychological distress at 
baseline, between groups. Sufficiently alike or controlled.  
Adequately addressed (1) Reasonable detail of psychological distress measure between 
groups, and somewhat alike at baseline. 
Poorly addressed (0) Measured but limited description, poorly alike at baseline. 
Not addressed (0)  






   




vii. The intervention is both sufficiently defined and delivered as planned (i.e. 
demonstrates good fidelity). 
Well-covered (2) The intervention is clearly outlined and shows good 
treatment fidelity – could be replicated. 
Adequately addressed (1) Some detail about the intervention, evidence of alteration of 
intervention from its original form. 
Poorly addressed (0) Unclear definition of the intervention and its fidelity.  
Not addressed (0)  
Not applicable (0)  
 
viii. The assignment of subjects to treatment and control groups is randomised 
Well-covered (2) Randomisation is clearly described using an appropriate 
method 
Adequately addressed (1) It is stated that randomisation is carried out, but no 
explanation of method. 
Poorly addressed (0) Randomisation is stated, but not using appropriate method.  
Not addressed (0)  
Not applicable (0)  
 
ix. Sample size adequate for analyses 
Well-covered (2) The number of participants who completed pre- and post-
intervention measures was sufficient to enable Power of at 
least 0.8 for simple main effects (uncontrolled trials) and 
interaction effects (where 2+ groups). Effect size was 
anticipated to be medium and alpha was 0.05. 
Adequately addressed (1) The number of participants who completed pre- and post-
intervention measures was sufficient to enable Power of at 
least 0.7 for simple main effects (uncontrolled trials) and 
interaction effects (where 2+ groups). Effect size was 
anticipated to be medium and alpha was 0.05. 
Poorly addressed (0) The number of participants who completed pre- and post-
intervention measures did not enable Power of at least 0.7 for 
simple main effects and interaction effects (where there are 
2+ groups). Effect size was anticipated to be medium and 
alpha was 0.05.  
 
Not addressed (0)  




   





x. Levels of attrition are reported, acceptable, and equivalent for treatment 
versus control 
Well-covered (2) Levels of attrition (from allocation to group to completion of 
post intervention measures) are clearly detailed for both 
treatment and control groups (where present) and are 
sufficiently alike between conditions (within 10% of each 
other and less than 20% of total participants) 
Adequately addressed (1) Reasonable description of attrition (from allocation to group 
to completion of post intervention measures), somewhat 
alike between conditions (within 20% of each other), less 
than 30% of total participants. 
Poorly addressed (0) Poorly described (lacking specifics), or significantly different 
between conditions. 
Not addressed (0) Not described 
Not applicable (0)  
 
xi. The intervention is evaluated for an appropriate duration 
Well-covered (2) Follow-up carried out for a minimum of 3 months (must 
include psychological distress measure) 
Adequately addressed (1) Follow-up carried out for a minimum of 1 month (must 
include psychological distress measure) 
Poorly addressed (0) Follow-up less than one month 
Not addressed (0) No follow-up 
Not applicable (0)  
 
xii. Appropriate analysis 
Well-covered (2) Analysis described sufficiently to determine that analyses 
conducted appropriately at post-intervention - appropriate 
statistics used, ITT where there is attrition. 
Adequately addressed (1) Reasonably clear that appropriate analysis carried out at 
post-intervention - appropriate statistics used, ITT where 
there is attrition – maybe lacking in clarity/detail about. 
Poorly addressed (0) Inappropriate analyses or not addressing attrition, where 
relevant, at post-intervention. 
Not addressed (0)  
Not applicable (0)  
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Appendix 2.  Author guidelines for Psychosomatic Medicine 
Manuscript formatting: Electronic manuscripts should be formatted so text is 
double-spaced (including references and tables) on 8 1/2"x 11" paper size. 
When submitting a manuscript, describe in a brief cover letter the paper's 
objectives and significance. The editor welcomes, but is not bound by, 
suggestions for possible peer reviewers. 
On the cover page, include the title, full names of author(s), with degrees and 
academic or professional affiliations, and the complete address, telephone 
number, fax number, and e-mail address of the author to whom proofs and 
correspondence should be sent. Indicate the total number of words contained 
in the manuscript, and the number of tables and figures; the word count 
should include the body of the paper, the references and the tables. If the title 
exceeds 45 characters, supply an abbreviated running title of fewer than 46 
spaces. Indicate whether the work was supported by the National Institutes of 
Health; Wellcome Trust, Howard Hughes Medical Institute, or others. If no 
support was received, please indicate that as well. Potential conflicts of 
interest should also be reported. Number pages consecutively beginning with 
the abstract page. Manuscripts should be no longer than 6,500 words. 
Abstract: All papers should include a brief initial abstract of not more than 
250 words followed by up to 6 key words for indexing. Abstracts should be 
submitted in outline format, using the bolded headings of Objective, Methods, 
Results, Conclusions, and, if applicable, Trial Registration. After the 
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keywords, list all acronyms used in text, e.g., DBP = diastolic blood pressure; 
BMI = body mass index. 
Tables and Illustrations: Tables should be double-spaced, including all 
headings, and should have a descriptive title. Each table should be 
numbered sequentially in Arabic numerals and begin on a new page. When 
preparing tables, if appropriate to the data, include the number of subjects, 
the statistical tests or estimation techniques used, p values, and some 
measure of variability (standard deviations, standard errors or confidence 
intervals) for any estimates (e.g., means, differences, proportions) presented. 
For figures, please do not use three-dimensional graphs for two-dimensional 
data. 
For line artwork, submit high-resolution digital files, 1200 dpi (please, no 
screens behind graphs). Please do not embed digital art in Microsoft Word or 
other word-processor files. For publishing, we require TIFF, EPS, or 
PowerPoint files. A separate sheet of legends for illustrations should be 
included. Authors wishing to use color figures will incur a fee to defray the 
associated printing costs. For further graphical details, 
seehttp://cpc.cadmus.com/da/guidelines.asp. 
References and Footnotes: In the text, citation of references is by full-sized 
numbers in parentheses. Footnotes to the text are indicated by Arabic 
numeral superscripts numbered consecutively throughout the paper and 
placed at the foot of each page on which they are cited. List references in the 
order cited in the text. Number references consecutively, using Arabic 
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numerals. References should be typed double-spaced and placed at the end 
of the text beginning on a separate page. List all authors; do not use "et al." 
The reference list should not include personal communications or 
manuscripts submitted but not accepted for publication. References should 
be styled as follows: 
Book: Tomb DA. Psychiatry. 5th ed. Baltimore: Williams & Wilkins; 1994. 
Edited Book: Gorman JR, Locke SE. Neural, endocrine, and immune 
interactions. In: Kaplan HI, Sadock BJ, editors. Comprehensive textbook of 
psychiatry. vol 1. 5th ed. Baltimore: Williams & Wilkins; 1989. p. 111-25. 
Journals: Irvine J, Baker B, Smith J, Jandciu S, Paquette M, Cairns J, 
Connolly S, Roberts R, Gent M, Dorian P. Poor adherence to placebo or 
amiodarone therapy predicts mortality: results from the CAMIAT study. 
Psychosom Med 1999;61:566-75. 
Periodical abbreviations should follow those given by Index Medicus. Correct 
journal abbreviations can be found by searching at: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=journals 
Upon acceptance of an article, authors will be asked to transfer copyright to 
the American Psychosomatic Society to ensure the widest possible 
dissemination of information under the U.S. Copyright Law. After acceptance, 
manuscripts are forwarded to the publisher, and questions regarding 
publication, reprints, proofs, etc. should be addressed to LWW. The 
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corresponding author receives proofs within several weeks of acceptance. 
Corrections should be to the publisher within 48 hours of receipt. 
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Appendix 3.  South of Scotland Research Ethics Committee 3 ethical approval 
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Appendix 4.  NHS Borders Research & Development Committee approval 
 






Borders General Hospital 
Melrose 
Roxburghshire TD6 9BS 
 
Telephone   01896 826719 




 Mrs Sarah McLaren 
NHS Borders 






Our Ref  11/BORD/17    
 
Enquiries to    Joy Borowska 




Dear Mrs McLaren 
11/BORD/17   Self help booklet for symptoms with no known medical origin 
Thank you for sending details of your study to NHS Borders. I can confirm that the Research 
Governance Committee has reviewed the documentation, and on this basis I am pleased to inform you 
that this study has management approval for commencement within NHS Borders. 
It is a condition of approval that everyone involved in this study abides by the guidelines/protocols 
implemented by NHS Borders with respect to confidentiality and Research Governance. It is your 
responsibility to ensure that you are familiar with these, however please do not hesitate to seek advice 
if you are unsure. 
Please advise the R&D Office immediately of any changes to the project such as amendments to 
the protocol, recruitment, funding, personnel or resource input required of NHS Borders. 
Please also advise the R&D office when recruitment has been completed and when the study has 
been fully completed. 
Amendments to the protocol will require approval from the ethics committee that approved your 
study.  Please inform this office when recruitment has closed and when the study has been completed.  
Please quote the reference number stated above in all correspondence. 
May I take this opportunity to wish you every success with your project? Please do not hesitate to 






Associate Medical Director (Clinical Governance) 
CC NRSCC  
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Appendix 5.  The University of Edinburgh Clinical Psychology training 
programme methodological approval 
 
UNIVERSITY OF EDINBURGH / NHS SCOTLAND  
CLINICAL PSYCHOLOGY TRAINING PROGRAMME 
FEEDBACK SHEET FOR THESIS PROPOSAL FORM (Not R1) 
 (Please Note that this is not the form for the Research 1 Assessed Thesis 
proposals)  
Marker: Ethel Quayle   Date Marked:30.10.11 
 Trainee: Sarah Miller 
Proposal Title:  The evaluation of a mindfulness-based self-help booklet for those 
with medically unexplained symptoms in primary care. 
 COMMENTS ON PROJECT VIABILITY 
Please provide feedback on potential risks to the project, the ways in which these 
may be addressed and any recommended or required changes to the project. Please 
ensure that it is clear which (if any) changes are required. 
The proposal provides an extensive review of the relevant literature which provides a good 
justification for the proposed research.  The research hypotheses and methodology is clearly 
outlined.  Using GP attendance is clearly one way of looking at the impact on health-related 
behaviours, but it might be useful to discriminate between attendance because of MUS 
symptoms and attendance for other reasons? For example, if the participant and fallen on ice and 
broken their leg they might have a high number of appointments but these would not be related 
to MUS. I am not clear from the proposal how you ascertain if the self-help package has been 
used or whether any improvement might be related to other factors, such as change in 
medication? Information given about sample size and proposed analysis is clearly presented, 
along with the rationale for achieving this. This is a well-presented and interesting proposal. 
MARKER’S RECOMMENDATION FOR PROJECT (PLEASE CIRCLE ONE 
OPTION BELOW): 
1. The project should proceed in broadly its current form √ 
2. The project should proceed broadly in its current form subject to outlined 
revisions (these should be clear from feedback above) 
3. The project should not proceed in its current form and should be reviewed 
further by the Research Committee 
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Appendix 6.  Participant information pack 
Appendix 6a: Participant information sheet 
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Appendix 6b: Patient introduction letter   
                                                                                                    






Dear Sir/Madam,  
 
Thank you for your interest in this research project.  You should find enclosed an 
information sheet about the project which will explain what would be involved in 
participating.  
When you have read the information sheet, if you would like to be involved in the 
project please complete the consent form and questionnaire and post them back to me 
in the enclosed envelope. If you have any questions or concerns about the project, 
please do not hesitate to contact me on the number above.  
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Appendix 6c: Consent form  
                                                                                                     
Consent form 
Self-help booklet for symptoms with no known medical origin 
Please tick each box to confirm you have read and agree, and sign and date below: 
 I confirm that I have read and understand the information sheet dated          
10/08/11 for the above study.           
 I have had the opportunity to consider the information, ask questions  
And have had these answered satisfactorily.          
 I understand that my participation is voluntary and that I am free to               
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected.          
 I understand that relevant sections of my medical records and data  
collected during the study may be looked at by responsible individuals  
from Edinburgh University where it is relevant to this research. I give 
permission for these individuals to have access to my records.    
 I agree to take part in the above research study.      
    
Signature:  _______________________________ Date: ____________ 
Name:  _______________________________   
Address: _______________________________ 
  _______________________________ 
  _______________________________ 
  _______________________________ 
 
If you agree to the above, please sign your name and fill in your name and address on 
this sheet and return alongside your completed questionnaire.    
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Appendix 7.  Intervention booklet 
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Appendix 8.  Ethical approval for project amendment 
 
Lothian NHS Board South East Scotland Research 
Ethics Committee 03 




Telephone 0131 536 9000 





Enquiries to Joyce Clearie 
Extension 35674 
 
Direct Line 0131 4655674 
Email joyce.clearie@nhslothian.scot.nhs.uk 
 
24 April 2012 
 
Mrs Sarah McLaren 
Trainee Clinical Psychologist 
NHS Borders 




Dear Mrs McLaren 
 
Study title: The development of a mindfulness-based self help 
booklet for those presenting with medically 
unexplained symptoms, and its evaluation using a 
randomly controlled trial measuring patient 
wellbeing and GP attendance. 
REC reference: 11/SS/0084 
Amendment number:  
Amendment date: 13 March 2012 
 




The members of the Committee taking part in the review gave a favourable ethical 
opinion of the amendment on the basis described in the notice of amendment 




The documents reviewed and approved at the meeting were: 
 
   




  Document   Version   Date   









Membership of the Committee 
 





All investigators and research collaborators in the NHS should notify the R&D 
office for the relevant NHS care organisation of this amendment and check 
whether it affects R&D approval of the research. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements 
for Research Ethics Committees and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
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Appendix 9.  R&D approval for project amendment 
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Appendix 10.  Additional letters 
Appendix 9a: Follow-up questionnaire letter 
                                                                                                 






Dear                         ,  
 
Thank you again for agreeing to participate in this research project.  
You should find enclosed a questionnaire similar to the ones you have already 
completed. Please complete this and post it back to us in the pre-paid envelope 
provided.  
If you have any questions or concerns whilst carrying this out, please do not hesitate 
to contact me on the number above.  
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Appendix 9b: Unreturned questionnaire letter  
                                                                                                    
 






Dear [insert name here],  
 
I have not received a completed questionnaire from you so I have enclosed another, 
alongside a pre-paid addressed envelope. Apologies if you have sent the 
questionnaire back in the last few days. If not, if you could take the 10-15 minutes to 
fill in the questionnaire and return it in the envelope provided we would be very 
grateful. 
If you have any questions or concerns whilst carrying this out, please do not hesitate 
to contact me on the number above.  
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Appendix 11.  GP questionnaire 
                                                                                                                                
Review of self-help project recruitment 
Thank you for helping to recruit participants to our project evaluating a self-help booklet for patients 
with medically unexplained symptoms (MUS). Unfortunately the response rate has been lower than 
forecast and we are trying to understand why so that we can make future studies more helpful to GPs 
and patients. 
Please take 2 minutes to complete this questionnaire. All responses will be anonymous. Please feel 
free to contact me on 07779007149 if you have any questions. 
Thank you, Sarah McLaren. 
1. Are you a GP?               Yes    No      (please circle)   if not please specify 
_____________________ 
2. Were you aware of this research project?        Yes     No       (please circle) 
3. Please estimate how many patients you have mentioned the project to:    __________ 
4. Please rate how true you find each of the following statements by ticking the appropriate box: 













1. I did not see patients with medically 
unexplained symptoms. 
          
2. I do not diagnose patients with the labels 
given in the inclusion criteria. 
          
3. I saw patients with MUS but they did not 
meet inclusion criteria. 
          
4. I did not feel that taking part in the research 
project was right for the patients I saw. 
          
5. I did not want to make extra demands on 
already distressed patients. 
          
6. I did not think that self-help would be 
suitable for patients I saw. 
          
7. I was very busy and forgot to offer potential 
patients inclusion in the project. 
          
8. It was difficult to prioritise the study in the 
face of competing demands. 
          
9. I think that a mindfulness approach would 
not be of benefit to the patients I saw. 
          
10. I felt that raising the research could detract 
from the focus of the consultation. 
          




Thank you again for taking the time to complete this questionnaire. 
